{
    "paper_id": "2a2b63068f960e3d9d4b867891d746df2594e9da",
    "metadata": {
        "title": "Standard Review Article A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology Introduction of Clinical Pharmacopsychology in the Rational Use of Clozapine in TRS",
        "authors": [
            {
                "first": "Psychother",
                "middle": [],
                "last": "Psychosom",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jose",
                "middle": [],
                "last": "De Leon A-C Can",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Mental Health Research Center at Eastern State Hospital",
                    "location": {
                        "settlement": "Lexington",
                        "region": "KY",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Jun",
                "middle": [],
                "last": "Ruan",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Key Laboratory of Mental Disorders, and Laboratory of Clinical Psychopharmacology",
                    "institution": "The National Clinical Research Centre for Mental Disorders",
                    "location": {
                        "settlement": "Beijing"
                    }
                },
                "email": ""
            },
            {
                "first": "Georgios",
                "middle": [],
                "last": "Schoretsanitis",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Northwell Health",
                    "location": {
                        "settlement": "Glen Oaks",
                        "region": "NY",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Carlos",
                "middle": [],
                "last": "De Las Cuevas",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of La Laguna",
                    "location": {
                        "settlement": "San Crist\u00f3bal de La Laguna",
                        "country": "Spain"
                    }
                },
                "email": ""
            },
            {
                "first": "Jose",
                "middle": [],
                "last": "De Leon",
                "suffix": "",
                "affiliation": {},
                "email": "jdeleon@uky.edu"
            },
            {
                "first": "Leon",
                "middle": [
                    "/"
                ],
                "last": "Ruan",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "/",
                "middle": [],
                "last": "Schoretsanitis",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "/",
                "middle": [],
                "last": "De Las Cuevas",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "Using Richardson and Davidson's model and the sciences of pharmacokinetics and clinical pharmacopsychology, this article reviewed the: (1) poor life expectancy associated with treatment-resistant schizophrenia (TRS), which may be improved in patients who adhere to clozapine; (2) findings that clozapine is the best treatment for TRS (according to efficacy, effectiveness and well-being); and (3) potential for clozapine to cause vulnerabilities, including potentially lethal adverse drug reactions such as agranulocytosis, pneumonia, and myocarditis. Rational use requires: (1) modification of the clozapine package insert worldwide to include lower doses for Asians and to avoid the lethality associated with pneumonia, (2) the use of clozapine levels for personalizing dosing, and (3) the use of slow and personalized titration. This may make clozapine as safe as possible and contribute to increased life expectancy and well-being. In the absence of data on COVID-19 in clozapine patients, clozapine possibly impairs immunological mechanisms and may increase pneumonia risk in infected patients. Psychiatrists should call their clozapine patients and families and explain to them that if the patient develops fever or flu-like symptoms, the psychiatrist should be called and should consider halving the clozapine dose. If the patient is hospitalized with pneumonia, the treating physician needs to assess for symptoms of clozapine intoxication since halving the dose may not be enough for all patients; consider decreasing it to one-third or even stopping it. Once the signs of inflammation and fever have disappeared, the clozapine dose can be slowly increased to the prior dosage level.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Psychiatric textbooks and article reviews in psychiatric journals ignore the recent scientific advances on the mechanism of adverse drug reactions (ADRs), pharmacokinetics, and clinical pharmacopsychology which are the basis for this article review on the rational use of clozapine for treatment-resistant schizophrenia (TRS).",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "In an editorial, Fava [1] first used the scheme of Richardson and Doster [2] to propose a rational use of antidepressants. Richardson and Doster [2] proposed that, in evidence-based medical decision-making for individual patients, three dimensions should be considered: (1) baseline risk of poor outcomes from an index disorder that is not treated, (2) responsiveness to the treatment option, and (3) vulnerability to ADRs. This approach is similar to the World Health Organization's (WHO) approach, which characterizes the rational use of medicine as, \"Patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and at the lowest cost to them and their community\" [3] .",
            "cite_spans": [
                {
                    "start": 17,
                    "end": 25,
                    "text": "Fava [1]",
                    "ref_id": null
                },
                {
                    "start": 145,
                    "end": 148,
                    "text": "[2]",
                    "ref_id": null
                },
                {
                    "start": 758,
                    "end": 761,
                    "text": "[3]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "This review first introduces the recent advances on ADRs, pharmacokinetics and clinical pharmacopsychology regarding clozapine. After this introduction, the following three sections apply Richardson and Doster's model to TRS, the main clozapine indication. Then the current use of clozapine is reviewed, and a new rational approach is proposed with our current recommendations regarding the COVID-19 infections. The last two sections of this review describe the technological advances that may influence future clozapine use and other clozapine indications.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "There are two major classes of ADRs: (1) unpredictable, uncommon and idiosyncratic, and (2) predictable, common and dose-related [4] . The latter are better described as related to serum concentrations [5] . There is recent agreement among the most important medical scientists, such as Vanderbroucke and Psaty [6] or Ioannidis [7] , that the status of ADR science is highly deficient. According to them, there are two main reasons for the poor status of ADR knowledge [6, 7]: (1) pharmaceutical companies tend to try to minimize the existence of ADRs, and (2) rare but potentially lethal ADRs, usually idiosyncratic, are usually not detected by the randomized clinical trials (RCTs) required for drug approval, since they are shortterm and include only a few thousand patients. These deficiencies have led to several drugs being withdrawn from the market due to unidentified potentially lethal ADRs [8] .",
            "cite_spans": [
                {
                    "start": 129,
                    "end": 132,
                    "text": "[4]",
                    "ref_id": null
                },
                {
                    "start": 202,
                    "end": 205,
                    "text": "[5]",
                    "ref_id": null
                },
                {
                    "start": 311,
                    "end": 314,
                    "text": "[6]",
                    "ref_id": null
                },
                {
                    "start": 328,
                    "end": 331,
                    "text": "[7]",
                    "ref_id": null
                },
                {
                    "start": 900,
                    "end": 903,
                    "text": "[8]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "ADRs and Clozapine"
        },
        {
            "text": "On the other hand, psychiatric textbooks and review articles call ADRs \"side effects\" and do not explain these two classes of limitations in the field. Similarly, recent review articles [9] [10] [11] stressed that clozapine is prone to cause ADRs but do not explain these advances in knowledge of ADRs.",
            "cite_spans": [
                {
                    "start": 186,
                    "end": 189,
                    "text": "[9]",
                    "ref_id": null
                },
                {
                    "start": 190,
                    "end": 194,
                    "text": "[10]",
                    "ref_id": null
                },
                {
                    "start": 195,
                    "end": 199,
                    "text": "[11]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "ADRs and Clozapine"
        },
        {
            "text": "A rational clozapine treatment needs first to be based on clozapine pharmacokinetics, which is a major determinant in clozapine dosing. Clozapine depends on the cytochrome P450 1A2 (CYP1A2) for its metabolism and follows pharmacokinetic changes similar to other CYP-1A2 drugs. This is not clearly explained in the US package insert. Online supplementary Box S1 (see www. karger.com/doi/10.1159/000507638 for all online suppl. material) [12-50] provides a critical chronology of the protracted history of the pharmacokinetics of clozapine, and the contributions of two other CYP1A2 drugs, theophylline and caffeine, to its understanding. The inhibitory effects of infections on CYP1A2 were first described in theophylline [15, 18, 19 Measuring serum clozapine levels, called therapeutic drug monitoring (TDM) by pharmacologists, is the cornerstone for the rational use of clozapine personalized dosing since a minimum serum level of 350 ng/mL is needed for clozapine response [51] . Pharmacokinetic science has determined that, in therapeutic dosages, clozapine follows linear kinetics (the relationship between dose and concentration is linear) and provides information on which variables influence clozapine clearance from the body and, therefore, clozapine dosing. The most important clozapine metabolite is norclozapine; clozapine-N-oxide is second. Norclozapine, clozapine-N-oxide, and other hydrosoluble metabolites are then eliminated by the kidney.",
            "cite_spans": [
                {
                    "start": 721,
                    "end": 725,
                    "text": "[15,",
                    "ref_id": null
                },
                {
                    "start": 726,
                    "end": 729,
                    "text": "18,",
                    "ref_id": null
                },
                {
                    "start": 730,
                    "end": 732,
                    "text": "19",
                    "ref_id": null
                },
                {
                    "start": 975,
                    "end": 979,
                    "text": "[51]",
                    "ref_id": "BIBREF2"
                }
            ],
            "ref_spans": [],
            "section": "Pharmacokinetic Introduction to the Rational Use of Clozapine in TRS"
        },
        {
            "text": "Clozapine clearance is measured by the concentrationto-dose (C/D) ratio. [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] describes the important pharmacokinetic variables for clozapine clearance. Higher clozapine C/D ratios, indicating lower clearance, are associated with females, non-smokers, Asians, genetic poor metabolizers, inhibitors, obesity, inflammation, and possibly with renal impairment and pregnancy. Lower clozapine C/D ratios indicate lack of adherence or higher clearance associated with males, smokers, non-Asians, and inducers.",
            "cite_spans": [
                {
                    "start": 73,
                    "end": 77,
                    "text": "[52]",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 78,
                    "end": 82,
                    "text": "[53]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 83,
                    "end": 87,
                    "text": "[54]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 88,
                    "end": 92,
                    "text": "[55]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 93,
                    "end": 97,
                    "text": "[56]",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 98,
                    "end": 102,
                    "text": "[57]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 103,
                    "end": 107,
                    "text": "[58]",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 108,
                    "end": 112,
                    "text": "[59]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 113,
                    "end": 117,
                    "text": "[60]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 118,
                    "end": 122,
                    "text": "[61]",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 123,
                    "end": 127,
                    "text": "[62]",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 128,
                    "end": 132,
                    "text": "[63]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 133,
                    "end": 137,
                    "text": "[64]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 138,
                    "end": 142,
                    "text": "[65]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 143,
                    "end": 147,
                    "text": "[66]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 148,
                    "end": 152,
                    "text": "[67]",
                    "ref_id": "BIBREF19"
                }
            ],
            "ref_spans": [],
            "section": "Pharmacokinetic Introduction to the Rational Use of Clozapine in TRS"
        },
        {
            "text": "Two prior TDM review articles [68, 69] are summarized in online supplementary Box S3 [31, 44, 50, 51, 55, 58-61, 63, 65, 68-91] which also describe our extensive experience with thousands of inpatient clozapine TDMs under standard conditions (trough and steady-state levels) in the US [44] and China [45, 65] . Many of these inpatients were followed for months and/or years after changes in important pharmacokinetic variables [31, 44, 50, 58-61, 63, 65, 74, 79, 86-91] .",
            "cite_spans": [
                {
                    "start": 30,
                    "end": 34,
                    "text": "[68,",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 35,
                    "end": 38,
                    "text": "69]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 85,
                    "end": 127,
                    "text": "[31, 44, 50, 51, 55, 58-61, 63, 65, 68-91]",
                    "ref_id": null
                },
                {
                    "start": 300,
                    "end": 304,
                    "text": "[45,",
                    "ref_id": null
                },
                {
                    "start": 305,
                    "end": 308,
                    "text": "65]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 427,
                    "end": 469,
                    "text": "[31, 44, 50, 58-61, 63, 65, 74, 79, 86-91]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Pharmacokinetic Introduction to the Rational Use of Clozapine in TRS"
        },
        {
            "text": "Published review articles [92] [93] [94] usually insist on the wide variability of clozapine TDM among individuals and the difficulty of interpreting a single clozapine level, but they fail to pay attention to findings from these two sciences: pharmacokinetics and clinical pharmacopsychology, which help in interpreting variability in clozapine levels. In inpatients, repeated measures allow the calculation of average clozapine clearance in an individual through a mean clozapine C/D ratio, which can be compared using dose-correction factors after changes in important pharmacokinetic variables (e.g., before and after use of an inhibitor).",
            "cite_spans": [
                {
                    "start": 26,
                    "end": 30,
                    "text": "[92]",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 31,
                    "end": 35,
                    "text": "[93]",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 36,
                    "end": 40,
                    "text": "[94]",
                    "ref_id": "BIBREF48"
                }
            ],
            "ref_spans": [],
            "section": "Pharmacokinetic Introduction to the Rational Use of Clozapine in TRS"
        },
        {
            "text": "When dealing with TDM in outpatients, one cannot ignore lack of adherence as a major problem in many clozapine outpatients, frequently leading to hospitalizations [95] [96] [97] [98] [99] . This is not surprising to the authors, who are interested in aiding the development of the science of clinical pharmacopsychology [100] . Lack of adherence is a major issue in treatment maintenance in psychiatry [101, 102] , and when analyzing outpatient samples, a low clozapine C/D ratio is almost never explained by the patient being a genetic ultrarapid metabolizer and rarely explained by co-prescription of a potent inducer; it is almost always explained by lack of adherence [46, 54, 87] . Unfortunately, experts who write reviews on clozapine TDM do not consider the major relevance of lack of adherence in clozapine outpatients. Clinicians do not appear to be free of this bias and seem to think that lack of adherence may be a problem for other patients, but their own patients are adherent. TDM results demonstrate that one-third to one-half of the patients considered TRS patients by their psychiatrists are simply not taking their antipsychotics [103, 104] . Unfortunately, no clozapine studies explored the pharmacopsychological variables influencing poor adherence. Based on the pattern of lack of adherence in psychiatric patients, one can hypothesize that each non-adherent clozapine patient may be influenced by one or more factors such as lack of insight about the illness, self-reported attitudes related to their history of medication exposure, or personality style related to feelings of control [105] . Addressing specific pharmacopsychological variables in each non-adherent patient has the potential to improve clozapine adherence.",
            "cite_spans": [
                {
                    "start": 163,
                    "end": 167,
                    "text": "[95]",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 168,
                    "end": 172,
                    "text": "[96]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 173,
                    "end": 177,
                    "text": "[97]",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 178,
                    "end": 182,
                    "text": "[98]",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 183,
                    "end": 187,
                    "text": "[99]",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 320,
                    "end": 325,
                    "text": "[100]",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 402,
                    "end": 407,
                    "text": "[101,",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 408,
                    "end": 412,
                    "text": "102]",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 677,
                    "end": 680,
                    "text": "54,",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 681,
                    "end": 684,
                    "text": "87]",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 1149,
                    "end": 1154,
                    "text": "[103,",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 1155,
                    "end": 1159,
                    "text": "104]",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 1608,
                    "end": 1613,
                    "text": "[105]",
                    "ref_id": "BIBREF60"
                }
            ],
            "ref_spans": [],
            "section": "Introduction of Clinical Pharmacopsychology in the Rational Use of Clozapine in TRS"
        },
        {
            "text": "The literature usually describes approximately onethird of schizophrenia patients as treatment-resistant, but the TRS definitions vary from study to study [106] . On the other hand, the literature agrees that: (1) clozapine is the most effective treatment for these patients [107, 108] and (2) among schizophrenia patients, those with treatment-resistant forms have the more obvious abnormalities in brain imaging [109, 110] , and are those associated with greater individual and societal burden [111] .",
            "cite_spans": [
                {
                    "start": 155,
                    "end": 160,
                    "text": "[106]",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 275,
                    "end": 280,
                    "text": "[107,",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 281,
                    "end": 285,
                    "text": "108]",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 414,
                    "end": 419,
                    "text": "[109,",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 420,
                    "end": 424,
                    "text": "110]",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 496,
                    "end": 501,
                    "text": "[111]",
                    "ref_id": "BIBREF66"
                }
            ],
            "ref_spans": [],
            "section": "Baseline Risk of Poor Outcomes from TRS without Treatment"
        },
        {
            "text": "To better understand the benefits and risks of clozapine in TRS, one would like to know the effects of TRS on life expectancy and how it is modified by clozapine or other antipsychotics; however, only data on schizophrenia in general is available. In a meta-analysis [112] , schizophrenia was associated with a weighted average of 14.5 years of potential life lost. In a recent Swedish cohort with > 20,000 patients, the cumulative antipsychotic exposure displays a U-shaped curve for overall mortality with no antipsychotic exposure having the worst outcome [113] . Regarding clozapine, in a meta-analysis of 24 studies with long-term follow-up of treatment, Vermeulen et al. [114] found long-term, crude mortality rate ratios were significantly lower in patients continuously treated with clozapine compared to patients treated with other antipsychotics (mortality rate ratio = 0.56). Online supplementary Box S4 [112] [113] [114] [115] [116] describes two additional studies published after the meta-analysis, also showing lower mortality in clozapine patients [115, 116] .",
            "cite_spans": [
                {
                    "start": 267,
                    "end": 272,
                    "text": "[112]",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 559,
                    "end": 564,
                    "text": "[113]",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 677,
                    "end": 682,
                    "text": "[114]",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 915,
                    "end": 920,
                    "text": "[112]",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 921,
                    "end": 926,
                    "text": "[113]",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 927,
                    "end": 932,
                    "text": "[114]",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 933,
                    "end": 938,
                    "text": "[115]",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 939,
                    "end": 944,
                    "text": "[116]",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 1064,
                    "end": 1069,
                    "text": "[115,",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 1070,
                    "end": 1074,
                    "text": "116]",
                    "ref_id": "BIBREF71"
                }
            ],
            "ref_spans": [],
            "section": "Baseline Risk of Poor Outcomes from TRS without Treatment"
        },
        {
            "text": "Online supplementary Box S5 describes in detail what we know regarding clozapine responsiveness measured by efficacy, effectiveness and well-being.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Baseline Risk of Poor Outcomes from TRS without Treatment"
        },
        {
            "text": "RCTs tend to be of relatively short duration, are biased against including the most severe patients in psychiatry [117] and are, therefore, far from ideal in assessing response in TRS. Later, RCTs are combined in meta-analyses, which Feinstein called \"statistical alchemy for the 21st century\" [118] . The most complex meta-analysis, the network meta-analysis, compares drugs indirectly, and these comparisons are particularly problematic when there is no similarity in the RCTs [119] .",
            "cite_spans": [
                {
                    "start": 114,
                    "end": 119,
                    "text": "[117]",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 294,
                    "end": 299,
                    "text": "[118]",
                    "ref_id": "BIBREF74"
                },
                {
                    "start": 479,
                    "end": 484,
                    "text": "[119]",
                    "ref_id": "BIBREF75"
                }
            ],
            "ref_spans": [],
            "section": "Efficacy: RCTs and Meta-Analysis"
        },
        {
            "text": "In a TRS meta-analysis, Siskind et al. [120, 121] found clozapine superiority. On the other hand, another research group using network meta-analyses published two articles; one by Samara et al. [122] found no clozapine superiority in TRS, but the other one by Huhn et al. [123] found that clozapine was the best antipsychotic for the acute treatment of multiple-episode schizophrenia in general. Not surprisingly, this TRS network metaanalysis by Samara et al. [122] has been criticized by lack of representativeness of the included RCTs [107, 124, 125] .",
            "cite_spans": [
                {
                    "start": 39,
                    "end": 44,
                    "text": "[120,",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 45,
                    "end": 49,
                    "text": "121]",
                    "ref_id": "BIBREF77"
                },
                {
                    "start": 194,
                    "end": 199,
                    "text": "[122]",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 272,
                    "end": 277,
                    "text": "[123]",
                    "ref_id": "BIBREF79"
                },
                {
                    "start": 461,
                    "end": 466,
                    "text": "[122]",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 538,
                    "end": 543,
                    "text": "[107,",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 544,
                    "end": 548,
                    "text": "124,",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 549,
                    "end": 553,
                    "text": "125]",
                    "ref_id": "BIBREF81"
                }
            ],
            "ref_spans": [],
            "section": "Efficacy: RCTs and Meta-Analysis"
        },
        {
            "text": "If one takes a more comprehensive view of what is important in clinical practice [126] , and considers effectiveness based on two systematic reviews of naturalistic cohort studies [127, 128] , clozapine was superior to other antipsychotics in decreasing discontinuation and decreasing hospitalization.",
            "cite_spans": [
                {
                    "start": 81,
                    "end": 86,
                    "text": "[126]",
                    "ref_id": "BIBREF82"
                },
                {
                    "start": 180,
                    "end": 185,
                    "text": "[127,",
                    "ref_id": "BIBREF83"
                },
                {
                    "start": 186,
                    "end": 190,
                    "text": "128]",
                    "ref_id": "BIBREF85"
                }
            ],
            "ref_spans": [],
            "section": "Effectiveness"
        },
        {
            "text": "The importance of well-being during pharmacotherapy is receiving more and more attention [129] and is particularly relevant in explaining the high adherence of some patients to clozapine, demonstrated by the lower discontinuation rates in cohort studies [127, 128] . Clozapine positive effects on well-being in some patients may be influenced by clozapine effects on extrapyramidal symptoms [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] , hostility [143, 144] and the \"awakening\" phenomenon [145] [146] [147] (online suppl. Box S5, section 3).",
            "cite_spans": [
                {
                    "start": 89,
                    "end": 94,
                    "text": "[129]",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 254,
                    "end": 259,
                    "text": "[127,",
                    "ref_id": "BIBREF83"
                },
                {
                    "start": 260,
                    "end": 264,
                    "text": "128]",
                    "ref_id": "BIBREF85"
                },
                {
                    "start": 391,
                    "end": 396,
                    "text": "[130]",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 397,
                    "end": 402,
                    "text": "[131]",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 403,
                    "end": 408,
                    "text": "[132]",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 409,
                    "end": 414,
                    "text": "[133]",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 415,
                    "end": 420,
                    "text": "[134]",
                    "ref_id": "BIBREF91"
                },
                {
                    "start": 421,
                    "end": 426,
                    "text": "[135]",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 427,
                    "end": 432,
                    "text": "[136]",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 433,
                    "end": 438,
                    "text": "[137]",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 439,
                    "end": 444,
                    "text": "[138]",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 445,
                    "end": 450,
                    "text": "[139]",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 451,
                    "end": 456,
                    "text": "[140]",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 457,
                    "end": 462,
                    "text": "[141]",
                    "ref_id": "BIBREF98"
                },
                {
                    "start": 463,
                    "end": 468,
                    "text": "[142]",
                    "ref_id": "BIBREF99"
                },
                {
                    "start": 481,
                    "end": 486,
                    "text": "[143,",
                    "ref_id": "BIBREF100"
                },
                {
                    "start": 487,
                    "end": 491,
                    "text": "144]",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 523,
                    "end": 528,
                    "text": "[145]",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 529,
                    "end": 534,
                    "text": "[146]",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 535,
                    "end": 540,
                    "text": "[147]",
                    "ref_id": "BIBREF104"
                }
            ],
            "ref_spans": [],
            "section": "Clozapine and Well-Being"
        },
        {
            "text": "The description of clozapine-induced agranulocytosis in 1975 [14] derailed its widespread use around the world (online suppl. Box S1). The next step was the marketing of clozapine in the US in 1990 [12] with the requirement of weekly white cell blood counts (WBC) and a manufacturer-managed database. Then clozapine was progressively marketed in multiple countries with different levels of WBC monitoring [148] . In the US in 2015 [41], the WBC requirements were modified, returning to a unified WBC database and allowing for lower levels of absolute neutrophil count (ANC) for starting patients with benign ethnic neutropenia, as had previously been done in the UK [149, 150] . Clinicians worldwide need to follow the respective regulations of their countries regarding WBC and ANC monitoring.",
            "cite_spans": [
                {
                    "start": 405,
                    "end": 410,
                    "text": "[148]",
                    "ref_id": "BIBREF105"
                },
                {
                    "start": 666,
                    "end": 671,
                    "text": "[149,",
                    "ref_id": null
                },
                {
                    "start": 672,
                    "end": 676,
                    "text": "150]",
                    "ref_id": "BIBREF107"
                }
            ],
            "ref_spans": [],
            "section": "Clozapine-Induced Agranulocytosis"
        },
        {
            "text": "Currently, agranulocytosis appears to be a well-managed risk. The WHO's database, VigiBase, has received reports on ADRs since 1968 from 134 drug agencies in countries around the world. Our VigiBase search on July 15, 2019, identified a 2% rate of fatal outcomes (550/34,931) due to agranulocytosis since the onset of clozapine use [49]. Online supplementary Box S6 [49, 151-155] reviews our current knowledge of clozapine-induced agranulocytosis.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Clozapine-Induced Agranulocytosis"
        },
        {
            "text": "The convergence of two historical findings (online suppl. Box S1) has finally led to the recent realization of the relevance of the association between clozapine and pneumonia and its lethality. The first historical finding was that inflammation releases cytokines that decrease the expression and activity of CYP1A2 with the potential of causing intoxication by CYP1A2 drugs. This was first demonstrated in theophylline [15, 18, 19] and then 25 years later in clozapine [30, 31] . Elevation of c-reactive protein (CRP) is a good marker that cytokines are being released, and that this may increase clozapine levels [156] . The second historical finding is that in 2005, the FDA modified the package insert of all second-generation antipsychotics to include a warning about death by pneumonia in patients with dementia [32] . Despite the fact that clozapine is not indicated for dementia, its package insert was modified, too. The association between clozapine and pneumonia is supported by data from the Taiwan registry [37] , other studies previously reviewed [49], and further verified by a mirror-image study in the Danish registry [157] .",
            "cite_spans": [
                {
                    "start": 471,
                    "end": 475,
                    "text": "[30,",
                    "ref_id": null
                },
                {
                    "start": 476,
                    "end": 479,
                    "text": "31]",
                    "ref_id": null
                },
                {
                    "start": 616,
                    "end": 621,
                    "text": "[156]",
                    "ref_id": "BIBREF113"
                },
                {
                    "start": 819,
                    "end": 823,
                    "text": "[32]",
                    "ref_id": null
                },
                {
                    "start": 1021,
                    "end": 1025,
                    "text": "[37]",
                    "ref_id": null
                },
                {
                    "start": 1136,
                    "end": 1141,
                    "text": "[157]",
                    "ref_id": "BIBREF114"
                }
            ],
            "ref_spans": [],
            "section": "Pneumonia"
        },
        {
            "text": "More concerning is that pneumonia can be highly lethal in clozapine patients and is one of the most impor-Psychother Psychosom DOI: 10.1159/000507638 tant causes of mortality in clozapine patients. This has been suggested by observational studies in the US [88, 158] , the UK [159, 160] , and Denmark [42] . Moreover, a VigiBase search [49] exploring pneumonia lethality in clozapine patients led to very concerning results: (1) 2,077 fatal outcomes (approximately four times higher than those associated with agranulocytosis), and (2) relatively high lethality of 30% (much higher than the 2% of agranulocytosis). Moreover, pneumonia was much more strongly associated with clozapine than the 3 most frequently prescribed second-generation antipsychotics; each of them had around 1/10 of the fatal outcomes of clozapine [161] . The lethality of pneumonia in clozapine patients is explained in that clozapine can contribute to pneumonia, and once pneumonia develops it can cause a clozapine intoxication; therefore, the combination of pneumonia and clozapine intoxication is highly lethal. This complex bidirectional association [162] is described in detail in online supplementary Box S7 [157, [163] [164] [165] [166] [167] [168] [169] . Our recommendations for decreasing the risk and lethality of pneumonia in clozapine patients are described in online supplementary Box S8 [65, 162, 170, 171] . The context for the clinical relevance of these recommendations is that pneumonia may be the most significant lifethreatening medical event connected with antipsychotic use [172] .",
            "cite_spans": [
                {
                    "start": 257,
                    "end": 261,
                    "text": "[88,",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 262,
                    "end": 266,
                    "text": "158]",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 276,
                    "end": 281,
                    "text": "[159,",
                    "ref_id": "BIBREF117"
                },
                {
                    "start": 282,
                    "end": 286,
                    "text": "160]",
                    "ref_id": "BIBREF118"
                },
                {
                    "start": 301,
                    "end": 305,
                    "text": "[42]",
                    "ref_id": null
                },
                {
                    "start": 820,
                    "end": 825,
                    "text": "[161]",
                    "ref_id": "BIBREF119"
                },
                {
                    "start": 1128,
                    "end": 1133,
                    "text": "[162]",
                    "ref_id": "BIBREF120"
                },
                {
                    "start": 1188,
                    "end": 1193,
                    "text": "[157,",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 1194,
                    "end": 1199,
                    "text": "[163]",
                    "ref_id": "BIBREF121"
                },
                {
                    "start": 1200,
                    "end": 1205,
                    "text": "[164]",
                    "ref_id": "BIBREF122"
                },
                {
                    "start": 1206,
                    "end": 1211,
                    "text": "[165]",
                    "ref_id": "BIBREF123"
                },
                {
                    "start": 1212,
                    "end": 1217,
                    "text": "[166]",
                    "ref_id": "BIBREF124"
                },
                {
                    "start": 1218,
                    "end": 1223,
                    "text": "[167]",
                    "ref_id": "BIBREF125"
                },
                {
                    "start": 1224,
                    "end": 1229,
                    "text": "[168]",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 1230,
                    "end": 1235,
                    "text": "[169]",
                    "ref_id": "BIBREF127"
                },
                {
                    "start": 1376,
                    "end": 1380,
                    "text": "[65,",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 1381,
                    "end": 1385,
                    "text": "162,",
                    "ref_id": "BIBREF120"
                },
                {
                    "start": 1386,
                    "end": 1390,
                    "text": "170,",
                    "ref_id": "BIBREF129"
                },
                {
                    "start": 1391,
                    "end": 1395,
                    "text": "171]",
                    "ref_id": "BIBREF130"
                },
                {
                    "start": 1571,
                    "end": 1576,
                    "text": "[172]",
                    "ref_id": "BIBREF131"
                }
            ],
            "ref_spans": [],
            "section": "Pneumonia"
        },
        {
            "text": "The controversy of clozapine-induced myocarditis is defined by two extreme positions first delineated in 2012 by Cohen et al. [35] . Australian experts think that with adequate monitoring clozapine-induced myocarditis is present in 3% of patients, and those who do not find an incidence of 3% among their patients are ignoring many cases [38] . The position of most clozapine experts in continental Europe is that clozapine-induced myocarditis is very rare. In the Danish registry, Rohde et al. [42] found an incidence of 0.03% and no fatal cases. If we assume that Danish clinicians do not know how to diagnose myocarditis and that they are missing 3% of cases with a mortality rate of 6%, the study by Rohde et al. [42] , should have identified 6 deaths associated with clozapine-induced myocarditis instead of no deaths [162] .",
            "cite_spans": [
                {
                    "start": 113,
                    "end": 130,
                    "text": "Cohen et al. [35]",
                    "ref_id": null
                },
                {
                    "start": 338,
                    "end": 342,
                    "text": "[38]",
                    "ref_id": null
                },
                {
                    "start": 482,
                    "end": 499,
                    "text": "Rohde et al. [42]",
                    "ref_id": null
                },
                {
                    "start": 704,
                    "end": 721,
                    "text": "Rohde et al. [42]",
                    "ref_id": null
                },
                {
                    "start": 823,
                    "end": 828,
                    "text": "[162]",
                    "ref_id": "BIBREF120"
                }
            ],
            "ref_spans": [],
            "section": "Myocarditis"
        },
        {
            "text": "A recent meta-analysis of clozapine-induced myocarditis provides estimations for these two positions by describing an event rate of 2% in 9 Australian samples and of 0.3% in 15 non-Australian samples [173] . This metaanalysis provided no reason for this roughly 10-fold difference between Australia and other countries.",
            "cite_spans": [
                {
                    "start": 200,
                    "end": 205,
                    "text": "[173]",
                    "ref_id": "BIBREF132"
                }
            ],
            "ref_spans": [],
            "section": "Myocarditis"
        },
        {
            "text": "Online supplementary Box S9 [38, 66, 162, [174] [175] [176] [177] [178] [179] describes our model of clozapine-induced myocarditis as a hypersensitivity reaction similar to when rapid titrations of lamotrigine induce Stevens-Johnson syndrome and how to prevent it. Online supplementary Box S10 [16, 21, 26, 27, 33, 36, 45, 46, 48, 50, 54, 58, 69, 87, [180] [181] [182] [183] [184] [185] [186] [187] further describes the published data supporting this model in which rapid clozapine titration is key to explaining clozapine-induced myocarditis. Any titration that is too fast for a specific patient can cause clozapine-induced myocarditis or, more correctly, any kind of clozapine-induced inflammation [66] . Our most important recommendation is to always use slow and personalized clozapine titration (online suppl. Table S2 ) and weekly CRP (online suppl. Box S9).",
            "cite_spans": [
                {
                    "start": 33,
                    "end": 36,
                    "text": "66,",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 37,
                    "end": 41,
                    "text": "162,",
                    "ref_id": "BIBREF120"
                },
                {
                    "start": 42,
                    "end": 47,
                    "text": "[174]",
                    "ref_id": null
                },
                {
                    "start": 48,
                    "end": 53,
                    "text": "[175]",
                    "ref_id": "BIBREF134"
                },
                {
                    "start": 54,
                    "end": 59,
                    "text": "[176]",
                    "ref_id": "BIBREF135"
                },
                {
                    "start": 60,
                    "end": 65,
                    "text": "[177]",
                    "ref_id": "BIBREF136"
                },
                {
                    "start": 66,
                    "end": 71,
                    "text": "[178]",
                    "ref_id": "BIBREF137"
                },
                {
                    "start": 72,
                    "end": 77,
                    "text": "[179]",
                    "ref_id": "BIBREF138"
                },
                {
                    "start": 294,
                    "end": 298,
                    "text": "[16,",
                    "ref_id": null
                },
                {
                    "start": 299,
                    "end": 302,
                    "text": "21,",
                    "ref_id": null
                },
                {
                    "start": 303,
                    "end": 306,
                    "text": "26,",
                    "ref_id": null
                },
                {
                    "start": 307,
                    "end": 310,
                    "text": "27,",
                    "ref_id": null
                },
                {
                    "start": 311,
                    "end": 314,
                    "text": "33,",
                    "ref_id": null
                },
                {
                    "start": 315,
                    "end": 318,
                    "text": "36,",
                    "ref_id": null
                },
                {
                    "start": 319,
                    "end": 322,
                    "text": "45,",
                    "ref_id": null
                },
                {
                    "start": 323,
                    "end": 326,
                    "text": "46,",
                    "ref_id": null
                },
                {
                    "start": 327,
                    "end": 330,
                    "text": "48,",
                    "ref_id": null
                },
                {
                    "start": 331,
                    "end": 334,
                    "text": "50,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 335,
                    "end": 338,
                    "text": "54,",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 339,
                    "end": 342,
                    "text": "58,",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 343,
                    "end": 346,
                    "text": "69,",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 347,
                    "end": 350,
                    "text": "87,",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 351,
                    "end": 356,
                    "text": "[180]",
                    "ref_id": "BIBREF139"
                },
                {
                    "start": 357,
                    "end": 362,
                    "text": "[181]",
                    "ref_id": "BIBREF140"
                },
                {
                    "start": 363,
                    "end": 368,
                    "text": "[182]",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 369,
                    "end": 374,
                    "text": "[183]",
                    "ref_id": "BIBREF142"
                },
                {
                    "start": 375,
                    "end": 380,
                    "text": "[184]",
                    "ref_id": "BIBREF143"
                },
                {
                    "start": 381,
                    "end": 386,
                    "text": "[185]",
                    "ref_id": "BIBREF144"
                },
                {
                    "start": 387,
                    "end": 392,
                    "text": "[186]",
                    "ref_id": "BIBREF145"
                },
                {
                    "start": 393,
                    "end": 398,
                    "text": "[187]",
                    "ref_id": "BIBREF146"
                },
                {
                    "start": 702,
                    "end": 706,
                    "text": "[66]",
                    "ref_id": "BIBREF18"
                }
            ],
            "ref_spans": [
                {
                    "start": 817,
                    "end": 825,
                    "text": "Table S2",
                    "ref_id": null
                }
            ],
            "section": "Myocarditis"
        },
        {
            "text": "Online supplementary Box S11 [49, 68, [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] explains that our VigiBase search [49] provided another four definitive clozapine ADRs associated with fatal outcomes: (1) constipation, (2) arrythmia, (3) seizures, and (4) syncope.",
            "cite_spans": [
                {
                    "start": 34,
                    "end": 37,
                    "text": "68,",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 38,
                    "end": 43,
                    "text": "[188]",
                    "ref_id": "BIBREF147"
                },
                {
                    "start": 44,
                    "end": 49,
                    "text": "[189]",
                    "ref_id": "BIBREF148"
                },
                {
                    "start": 50,
                    "end": 55,
                    "text": "[190]",
                    "ref_id": "BIBREF149"
                },
                {
                    "start": 56,
                    "end": 61,
                    "text": "[191]",
                    "ref_id": "BIBREF150"
                },
                {
                    "start": 62,
                    "end": 67,
                    "text": "[192]",
                    "ref_id": "BIBREF151"
                },
                {
                    "start": 68,
                    "end": 73,
                    "text": "[193]",
                    "ref_id": "BIBREF152"
                },
                {
                    "start": 74,
                    "end": 79,
                    "text": "[194]",
                    "ref_id": "BIBREF153"
                },
                {
                    "start": 80,
                    "end": 85,
                    "text": "[195]",
                    "ref_id": "BIBREF154"
                },
                {
                    "start": 86,
                    "end": 91,
                    "text": "[196]",
                    "ref_id": "BIBREF155"
                },
                {
                    "start": 92,
                    "end": 97,
                    "text": "[197]",
                    "ref_id": "BIBREF156"
                },
                {
                    "start": 98,
                    "end": 103,
                    "text": "[198]",
                    "ref_id": "BIBREF157"
                },
                {
                    "start": 104,
                    "end": 109,
                    "text": "[199]",
                    "ref_id": "BIBREF158"
                },
                {
                    "start": 110,
                    "end": 115,
                    "text": "[200]",
                    "ref_id": "BIBREF159"
                },
                {
                    "start": 116,
                    "end": 121,
                    "text": "[201]",
                    "ref_id": "BIBREF160"
                },
                {
                    "start": 122,
                    "end": 127,
                    "text": "[202]",
                    "ref_id": "BIBREF161"
                },
                {
                    "start": 128,
                    "end": 133,
                    "text": "[203]",
                    "ref_id": "BIBREF162"
                },
                {
                    "start": 134,
                    "end": 139,
                    "text": "[204]",
                    "ref_id": "BIBREF163"
                },
                {
                    "start": 140,
                    "end": 145,
                    "text": "[205]",
                    "ref_id": "BIBREF164"
                },
                {
                    "start": 146,
                    "end": 151,
                    "text": "[206]",
                    "ref_id": "BIBREF165"
                },
                {
                    "start": 152,
                    "end": 157,
                    "text": "[207]",
                    "ref_id": "BIBREF166"
                }
            ],
            "ref_spans": [],
            "section": "Other Potentially Lethal Clozapine ADRs"
        },
        {
            "text": "Clozapine is one of the antipsychotics most strongly associated with weight gain, hyperglycemia, and hyperlipidemia [208, 209] . In a systematic review of cohort studies, clozapine was also associated with higher cardiometabolic-related risk outcomes [128] . As described before, clozapine is associated with longer survival [114] ; it appears that its positive effects may outweigh its metabolic risks.",
            "cite_spans": [
                {
                    "start": 116,
                    "end": 121,
                    "text": "[208,",
                    "ref_id": "BIBREF167"
                },
                {
                    "start": 122,
                    "end": 126,
                    "text": "209]",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 251,
                    "end": 256,
                    "text": "[128]",
                    "ref_id": "BIBREF85"
                },
                {
                    "start": 325,
                    "end": 330,
                    "text": "[114]",
                    "ref_id": "BIBREF69"
                }
            ],
            "ref_spans": [],
            "section": "Other Potentially Lethal Clozapine ADRs"
        },
        {
            "text": "Behavioral ADRs secondary to psychiatric medications have not received enough attention [131, 132] and one of the best examples is clozapine-induced severe obsessive-compulsive symptoms (OCS). Due to its complexity and lack of good studies, there is no agreement in the literature on its management. In this journal issue, Kim et al. [210] reviewed the limited available literature and provided the very helpful conclusion that adding aripiprazole with/without clozapine dose reduction may be a good alternative to antidepressants for managing clozapine-associated OCS. Future controlled studies will need to clarify whether this conclusion is correct or not.",
            "cite_spans": [
                {
                    "start": 88,
                    "end": 93,
                    "text": "[131,",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 94,
                    "end": 98,
                    "text": "132]",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 334,
                    "end": 339,
                    "text": "[210]",
                    "ref_id": "BIBREF170"
                }
            ],
            "ref_spans": [],
            "section": "Behavioral ADRs"
        },
        {
            "text": "Clozapine is the second-generation antipsychotic most consistently associated with withdrawal symptoms [211] . Thus, clinicians should warn patients not to stop clozapine suddenly, since it has been associated with several withdrawal syndromes including: (1) cholinergic re-6 DOI: 10.1159/000507638 bound (including nausea, vomiting, diarrhea, headache, agitation, confusion, and diaphoresis) [212] , (2) worsening psychosis and/or abnormal movements [213] , and (3) even catatonic symptoms in patients who never had catatonia before [91] . When clozapine needs to be stopped suddenly due to serious ADRs, temporary treatment with anticholinergics with slow titration over 2-3 weeks may be a good option for preventing cholinergic rebound [212] and olanzapine may be a reasonable choice [214] for covering withdrawal from psychosis or abnormal movements. Although we do not recommend rapid titration in na\u00efve patients, we have, on rare occasions, used it under very controlled inpatient conditions when previously known patients had severe withdrawal with psychotic exacerbations, or catatonia. These are extremely dangerous situations, and the sedating properties of clozapine can help as long as the patient is closely observed and the prior dosage needed to stabilize the patient and the level of tolerance are known.",
            "cite_spans": [
                {
                    "start": 103,
                    "end": 108,
                    "text": "[211]",
                    "ref_id": "BIBREF171"
                },
                {
                    "start": 393,
                    "end": 398,
                    "text": "[212]",
                    "ref_id": "BIBREF172"
                },
                {
                    "start": 451,
                    "end": 456,
                    "text": "[213]",
                    "ref_id": "BIBREF173"
                },
                {
                    "start": 534,
                    "end": 538,
                    "text": "[91]",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 739,
                    "end": 744,
                    "text": "[212]",
                    "ref_id": "BIBREF172"
                },
                {
                    "start": 787,
                    "end": 792,
                    "text": "[214]",
                    "ref_id": "BIBREF174"
                }
            ],
            "ref_spans": [],
            "section": "Behavioral ADRs"
        },
        {
            "text": "A phenomenon even less well described in the literature is that some patients who have shown remarkable improvement in their psychosis and then stopped clozapine on their own never again recovered the dramatic response seen the first time [215, 216] . Clinicians need to explain to any patient with dramatic response to clozapine that this may sometimes be lost by stopping clozapine.",
            "cite_spans": [
                {
                    "start": 239,
                    "end": 244,
                    "text": "[215,",
                    "ref_id": "BIBREF175"
                },
                {
                    "start": 245,
                    "end": 249,
                    "text": "216]",
                    "ref_id": "BIBREF176"
                }
            ],
            "ref_spans": [],
            "section": "Behavioral ADRs"
        },
        {
            "text": "In patients na\u00efve to clozapine, the most important contraindication is the presence of some kind of myeloproliferative disorder or neutropenia that precludes having a high enough ANC required to start clozapine. Very rarely, patients can develop allergic reactions to clozapine and should not be exposed again. Most of the contraindications that a clinician faces are relative contraindications in which the risk of starting clozapine needs to be carefully balanced by including the patient and the family in the discussion regarding the risks, avoiding DDIs before starting clozapine as much as possible and stabilizing medical problems as much as possible [207] . In many patients, clozapine may be the last option after exhausting all other options with limited benefit.",
            "cite_spans": [
                {
                    "start": 658,
                    "end": 663,
                    "text": "[207]",
                    "ref_id": "BIBREF166"
                }
            ],
            "ref_spans": [],
            "section": "Contraindications"
        },
        {
            "text": "Most clozapine experts are concerned by the lack of use of clozapine worldwide, in spite of its benefit for TRS. An international study including 17 countries showed that in most countries clozapine use increased from 2005 to 2014. Nevertheless, great disparities were seen, with greatest use in Finland (189/100,000 persons) and New Zealand (116/100,000), and least in the Japanese cohort (0.6/100,000) and in the privately insured US cohort (14/100,000) [217] . The term \"clozaphobia,\" phobia of prescribers toward prescribing clozapine, has been proposed [218] . Online supplementary Box S12 describes barriers regarding clozapine use and successes in the Netherlands and New Zealand in increasing clozapine use [219] [220] [221] [222] [223] [224] [225] .",
            "cite_spans": [
                {
                    "start": 456,
                    "end": 461,
                    "text": "[217]",
                    "ref_id": "BIBREF177"
                },
                {
                    "start": 558,
                    "end": 563,
                    "text": "[218]",
                    "ref_id": "BIBREF178"
                },
                {
                    "start": 715,
                    "end": 720,
                    "text": "[219]",
                    "ref_id": "BIBREF180"
                },
                {
                    "start": 721,
                    "end": 726,
                    "text": "[220]",
                    "ref_id": "BIBREF181"
                },
                {
                    "start": 727,
                    "end": 732,
                    "text": "[221]",
                    "ref_id": "BIBREF182"
                },
                {
                    "start": 733,
                    "end": 738,
                    "text": "[222]",
                    "ref_id": "BIBREF183"
                },
                {
                    "start": 739,
                    "end": 744,
                    "text": "[223]",
                    "ref_id": "BIBREF184"
                },
                {
                    "start": 745,
                    "end": 750,
                    "text": "[224]",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 751,
                    "end": 756,
                    "text": "[225]",
                    "ref_id": "BIBREF186"
                }
            ],
            "ref_spans": [],
            "section": "Current Use"
        },
        {
            "text": "A more rational use of clozapine is based on three pillars: (1) modification of the worldwide clozapine package insert reflecting the advances in clozapine pharmacokinetics, (2) the use of clozapine TDM to personalize clozapine dosing, and (3) the use of slow and personalized titration including CRP to avoid myocarditis and other clozapine-induced inflammations.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Proposal for More Rational Use of Clozapine"
        },
        {
            "text": "Clozapine package inserts worldwide should report that [47]: (1) Asians need half the dose prescribed in the US, (2) clinicians should be aware that pneumonia may be highly lethal in clozapine patients, and (3) clozapineinduced myocarditis during dose escalation can be reduced by slow personalized titration.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Changing Worldwide Clozapine Package Inserts"
        },
        {
            "text": "TDM is recommended by the AGNP experts but is not mandatory in any country. In the opinion of the authors, the use of clozapine should become similar to the use of lithium, which requires TDM for dosing. Many countries do not have access to clozapine TDM; therefore, it is not reasonable to make TDM mandatory. However, ideally all countries should provide access to clozapine TDM; it is the best way of personalizing dosing since it reflects the combination of genetic, environmental and personal variables that influence dosing and the specific pharmacokinetics of each drug [5]. Moreover, due to clozapine ADRs and variability in dosing, clozapine TDM is costeffective [226] .",
            "cite_spans": [
                {
                    "start": 672,
                    "end": 677,
                    "text": "[226]",
                    "ref_id": "BIBREF187"
                }
            ],
            "ref_spans": [],
            "section": "The Best Way to Personalize Maintenance Dosing Is TDM if It Is Available"
        },
        {
            "text": "Clozapine TDM is the best way to personalize the best maintenance dose to reach at least 350 ng/ml of serum clozapine concentrations [69] . To rule out lack of response, this clozapine dose should be maintained for Psychother Psychosom DOI: 10.1159/000507638 enough time; some have proposed 3 months [106] and others, 8 weeks [227] . Prescribing the lowest dose that delivers therapeutic concentrations and efficacy will decrease the risk of clozapine ADRs and provide the safest baseline in case there are infections or inflammations in the future. Moreover, clozapine TDM helps to determine adherence of clozapine outpatients which may predict rehospitalization [95] [96] [97] [98] [99] .",
            "cite_spans": [
                {
                    "start": 133,
                    "end": 137,
                    "text": "[69]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 300,
                    "end": 305,
                    "text": "[106]",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 326,
                    "end": 331,
                    "text": "[227]",
                    "ref_id": "BIBREF188"
                },
                {
                    "start": 664,
                    "end": 668,
                    "text": "[95]",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 669,
                    "end": 673,
                    "text": "[96]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 674,
                    "end": 678,
                    "text": "[97]",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 679,
                    "end": 683,
                    "text": "[98]",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 684,
                    "end": 688,
                    "text": "[99]",
                    "ref_id": "BIBREF53"
                }
            ],
            "ref_spans": [],
            "section": "The Best Way to Personalize Maintenance Dosing Is TDM if It Is Available"
        },
        {
            "text": "Psychiatrists with no access to clozapine TDM can use online supplementary Table S1 , which shows the average clozapine dose recommended based on ethnicity, sex, smoking, and some DDIs. Due to difficulty in predicting clozapine dosage in patients taking fluvoxamine, as it is a potent inhibitor [55, 228] , we do not recommend co-prescribing this drug with clozapine without TDM. As valproic acid can be an inhibitor of clozapine metabolism and an inducer of norclozapine metabolism, it is also better to avoid it [57] .",
            "cite_spans": [
                {
                    "start": 295,
                    "end": 299,
                    "text": "[55,",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 300,
                    "end": 304,
                    "text": "228]",
                    "ref_id": "BIBREF189"
                },
                {
                    "start": 514,
                    "end": 518,
                    "text": "[57]",
                    "ref_id": "BIBREF9"
                }
            ],
            "ref_spans": [
                {
                    "start": 75,
                    "end": 83,
                    "text": "Table S1",
                    "ref_id": null
                }
            ],
            "section": "The Best Way to Personalize Maintenance Dosing Is TDM if It Is Available"
        },
        {
            "text": "The Dutch clozapine guideline recommends slow titration with very slow titration for outpatients [223] . This may explain the lack of clozapine-induced myocarditis in the Netherlands. Therefore, there is little need for improving clozapine titration in the Netherlands.",
            "cite_spans": [
                {
                    "start": 97,
                    "end": 102,
                    "text": "[223]",
                    "ref_id": "BIBREF184"
                }
            ],
            "ref_spans": [],
            "section": "Slow and Personalized Titration with CRP Levels"
        },
        {
            "text": "In many other countries, personalized titration based on pharmacokinetic variables may be beneficial. Online supplementary Table S2 provides our recommendations for inpatient titrations and online supplementary Box S9 provides recommendations for preventing clozapine-induced myocarditis. Unfortunately, two unpredictable variables can make a patient behave as a clozapine poor metabolizer: genetics or undetected inflammations. To prevent those situations, our inpatient protocol recommends measuring CRP at the same time as WBC: at baseline and for the first 8 weeks of clozapine titration or until the final clozapine dose is reached. Measuring weekly CRP levels is much easier and less expensive than the intensive heart monitoring recommended by Australian experts [38, 178, 179] . Clozapine should not be started until CRP is normal, so that use of clozapine in patients with unidentified inflammations can be avoided. Subsequently, if the CRP is increased or the patient develops fever, this is a sign that the titration is too rapid for that patient, and the clozapine dose should not be further increased until CRP has normalized; this may prevent the progression of a clozapine-induced inflammation.",
            "cite_spans": [
                {
                    "start": 775,
                    "end": 779,
                    "text": "178,",
                    "ref_id": "BIBREF137"
                },
                {
                    "start": 780,
                    "end": 784,
                    "text": "179]",
                    "ref_id": "BIBREF138"
                }
            ],
            "ref_spans": [
                {
                    "start": 123,
                    "end": 131,
                    "text": "Table S2",
                    "ref_id": null
                }
            ],
            "section": "Slow and Personalized Titration with CRP Levels"
        },
        {
            "text": "There is no data on COVID-19 in clozapine patients but, based on what we know about clozapine pharmacology, we can hypothesize that clozapine, possibly by impairing immunological mechanisms, may increase the risk of pneumonia in infected patients. More importantly, during this CODIV-19 epidemic, psychiatrists should call their clozapine patients and families and explain to them that if the patient develops fever or flu-like symptoms, they should call their psychiatrist, and if they cannot reach their psychiatrist, the patient should cut the clozapine dose in half. If the patient has to be admitted to a hospital due to COVID-19 pneumonia, the treating physician needs to assess for symptoms of clozapine intoxication since halving the dose may not be enough for all patients and consider decreasing it to one-third or even stopping it. Once the signs of inflammation and fever have disappeared, the clozapine dose can be slowly increased to the prior dosage level.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "COVID-19 Infections"
        },
        {
            "text": "Online supplementary Box S13 [54, 155, [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] describes the recent commercialization and/or development of new technologies in pharmacogenetic testing, WBC monitoring, and TDM. The current commercial pharmacogenetic tests should not be used on clozapine patients. Currently, it is not clear whether the point of care devices providing WBC or TDM can facilitate clozapine prescription, or only make it more expensive. It is too early to decide whether some of the TDM technologies in development will provide easy and cheap ways to establish clozapine adherence.",
            "cite_spans": [
                {
                    "start": 29,
                    "end": 33,
                    "text": "[54,",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 34,
                    "end": 38,
                    "text": "155,",
                    "ref_id": "BIBREF112"
                },
                {
                    "start": 39,
                    "end": 44,
                    "text": "[229]",
                    "ref_id": "BIBREF190"
                },
                {
                    "start": 45,
                    "end": 50,
                    "text": "[230]",
                    "ref_id": "BIBREF191"
                },
                {
                    "start": 51,
                    "end": 56,
                    "text": "[231]",
                    "ref_id": "BIBREF192"
                },
                {
                    "start": 57,
                    "end": 62,
                    "text": "[232]",
                    "ref_id": "BIBREF193"
                },
                {
                    "start": 63,
                    "end": 68,
                    "text": "[233]",
                    "ref_id": "BIBREF194"
                },
                {
                    "start": 69,
                    "end": 74,
                    "text": "[234]",
                    "ref_id": "BIBREF196"
                },
                {
                    "start": 75,
                    "end": 80,
                    "text": "[235]",
                    "ref_id": "BIBREF197"
                },
                {
                    "start": 81,
                    "end": 86,
                    "text": "[236]",
                    "ref_id": "BIBREF198"
                },
                {
                    "start": 87,
                    "end": 92,
                    "text": "[237]",
                    "ref_id": "BIBREF199"
                },
                {
                    "start": 93,
                    "end": 98,
                    "text": "[238]",
                    "ref_id": "BIBREF200"
                },
                {
                    "start": 99,
                    "end": 104,
                    "text": "[239]",
                    "ref_id": "BIBREF201"
                },
                {
                    "start": 105,
                    "end": 110,
                    "text": "[240]",
                    "ref_id": "BIBREF202"
                },
                {
                    "start": 111,
                    "end": 116,
                    "text": "[241]",
                    "ref_id": "BIBREF203"
                }
            ],
            "ref_spans": [],
            "section": "Future Use: Technology Advances Coming to Market"
        },
        {
            "text": "This review article focuses on the use of monotherapy clozapine for TRS, which is the main clozapine indication in the US and other countries [148, 242] . We do not know how clozapine changes the life expectancy of patients with other clozapine indications, enumerated in online supplementary Box S14 [29, 139-141, 148, 207, 242-257] . To decide to prescribe clozapine for any of these indications requires the psychiatrist to carefully balance, for each patient, the likelihood of responsiveness and vulnerabilities, remembering that data on responsiveness is limited. If the same clozapine doses for de TRS are used for other indications, the clozapine vulnerabilities and ADRs should be similar. In the experience of the authors, other indications, such as polydipsia or intellectual disability with self-injurious behaviors, may respond to lower clozapine doses and do not require reaching concentrations of 350 ng/ml to gain efficacy [207] . Clozapine dosing and TDM need to be explored by future studies focusing on these other indications. As clozapine may be a last resource for inpatients with extremely severe conditions besides TRS, for which providers have exhausted all other options, each patient with these other conditions should be considered on an individual basis after discussing it with the patient and the family.",
            "cite_spans": [
                {
                    "start": 142,
                    "end": 147,
                    "text": "[148,",
                    "ref_id": "BIBREF105"
                },
                {
                    "start": 148,
                    "end": 152,
                    "text": "242]",
                    "ref_id": "BIBREF204"
                },
                {
                    "start": 306,
                    "end": 333,
                    "text": "139-141, 148, 207, 242-257]",
                    "ref_id": null
                },
                {
                    "start": 602,
                    "end": 604,
                    "text": "de",
                    "ref_id": null
                },
                {
                    "start": 939,
                    "end": 944,
                    "text": "[207]",
                    "ref_id": "BIBREF166"
                }
            ],
            "ref_spans": [],
            "section": "Other Clozapine Indications"
        },
        {
            "text": "Using Richardson and Davidson's model [2] and the sciences of pharmacokinetics and clinical pharmacopsychology, this article reviewed the: (1) poor life expectancy associated with TRS, which may be improved in patients who adhere to clozapine; (2) findings that clozapine is the best treatment for TRS (according to efficacy, effectiveness and well-being); and (3) potential for clozapine to cause vulnerabilities, including potentially lethal ADRs. Our proposal for rational use is based on three pillars: (1) modification of the clozapine package insert worldwide to reflect the advances in clozapine pharmacokinetics, (2) the use of clozapine TDM for personalizing clozapine dosing, and (3) the use of slow and personalized clozapine titrations. This proposal should make clozapine as safe as possible and may contribute to increasing the life expectancy of TRS patients taking clozapine and their well-being. Only time will tell whether this editorial accomplished its goal or further contributed to clozaphobia. author is grateful to the multiple reviewers reviewing his clozapine articles published during 2019 and the first 3 months in 2020; some of their suggestions were also used in this article.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Other Clozapine Indications"
        },
        {
            "text": "This article received no support from any funding agency, commercial business, or not-for-profit institution. In the last 3 years, the authors have had no commercial conflicts of interest.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Disclosure Statement"
        },
        {
            "text": "None. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Funding Sources"
        }
    ],
    "bib_entries": {
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Rapid titration and decreased clozapine clearance may help explain five cases of clozapine-induced myocarditis in a New York hospital",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "Rhee",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kondracke",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Diuguid-Gerber",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Psychosomatics",
            "volume": "61",
            "issn": "1",
            "pages": "102--105",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hiemke",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Bergemann",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "W"
                    ],
                    "last": "Clement",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Conca",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Deckert",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Domschke",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Pharmacopsychiatry",
            "volume": "51",
            "issn": "1-02",
            "pages": "9--62",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dobrinas",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cornuz",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Oneda",
                    "suffix": ""
                },
                {
                    "first": "Kohler",
                    "middle": [],
                    "last": "Serra",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Puhl",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Eap",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "B"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "The dosing of atypical antipsychotics",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Armstrong",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Cozza",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "",
            "volume": "46",
            "issn": "",
            "pages": "262--73",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Is there a future for CY-P1A2 pharmacogenetics in the optimal dosing of clozapine? Pharmacogenetics",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.2217/pgs-2020-0015"
                ]
            }
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Assessing drugdrug interactions through therapeutic drug monitoring when administering oral secondgeneration antipsychotics",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Spina",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hiemke",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Expert Opin Drug Metab Toxicol",
            "volume": "12",
            "issn": "4",
            "pages": "407--429",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Delayed drug interactions in psychiatry: armodafinil and risperidone as a potential case in point",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Andrade",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "J Clin Psychiatry",
            "volume": "76",
            "issn": "12",
            "pages": "1633--1637",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Future studies on the interaction between clozapine and valproic acid should aspire to include longitudinal designs and free valproate concentrations and should consider that inducer and/or inhibitory effects may vary with time, the individual and the autoinduction of valproic acid",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Ther Drug Monit",
            "volume": "42",
            "issn": "1",
            "pages": "159--61",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Adding oral contraceptives to clozapine may require halving the clozapine dose: a new case and a literature review",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Schoretsanitis",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Kane",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Clin Psychopharmacol. Forthcoming",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Clozapine levels and caffeine",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Odom-White",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "J Clin Psychiatry",
            "volume": "57",
            "issn": "4",
            "pages": "175--181",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Interaction of sertraline with clozapine",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "R"
                    ],
                    "last": "Pinninti",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Clin Psychopharmacol",
            "volume": "17",
            "issn": "2",
            "pages": "119--139",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Adding other antipsychotics to clozapine",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Cooke",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Clin Psychiatry",
            "volume": "60",
            "issn": "10",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Abrupt decrease of clozapine plasma concentration after discontinuation of flupentixol comedication",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wagner",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kluge",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Clin Psychopharmacol",
            "volume": "39",
            "issn": "2",
            "pages": "168--177",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Gemfibrozil may decrease norclozapine elimination: a case report",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Barclay",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Mccollum",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Schoretsanitis",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Clin Psychopharmacol",
            "volume": "39",
            "issn": "4",
            "pages": "405--412",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "J"
                    ],
                    "last": "Diaz",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Santoro",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Spina",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cogollo",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "E"
                    ],
                    "last": "Rivera",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Botts",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Pharmacopsychiatry",
            "volume": "41",
            "issn": "3",
            "pages": "81--91",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Around 3% of 1,300 Levels Were Elevated during Infections in a Retrospective Review of 131 Beijing Hospital In-Patients with More than 24,000 Days of Clozapine Treatment",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "N"
                    ],
                    "last": "Zang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "Y"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Psychother Psychosom",
            "volume": "1",
            "issn": "3",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1159/000506355"
                ]
            }
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Verdoux",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Quiles",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Schizophr Res",
            "volume": "211",
            "issn": "",
            "pages": "1--9",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "National Institute for Child Health and Human Development Network of Maternal-Fetal-Medicine Units. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "S"
                    ],
                    "last": "Tracy",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Venkataramanan",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "D"
                    ],
                    "last": "Glover",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "N"
                    ],
                    "last": "Caritis",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Am J Obstet Gynecol",
            "volume": "192",
            "issn": "2",
            "pages": "633--642",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Schoretsanitis",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Kane",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Spina",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hiemke",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Expert Rev Clin Pharmacol",
            "volume": "12",
            "issn": "7",
            "pages": "603--624",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Using therapeutic drug monitoring to personalize clozapine dosing in Asians",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Schoretsanitis",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Kane",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Ruan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Asia Pac Psychiatry",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1111/appy.12384"
                ]
            }
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Clozapine administered once versus twice daily: does it make a difference? Med Hypotheses",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Procyshyn",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Vila-Rodriguez",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "G"
                    ],
                    "last": "Honer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Barr",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "",
            "volume": "82",
            "issn": "",
            "pages": "225--233",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Plasma protein and lipoprotein distribution of clozapine",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Procyshyn",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "B"
                    ],
                    "last": "Kennedy",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Marriage",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Wasan",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Am J Psychiatry",
            "volume": "158",
            "issn": "6",
            "pages": "949--51",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Competitive displacement of clozapine from plasma proteins in normolipidemic and hyperlipidemic plasma samples: clinical implications",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Procyshyn",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ho",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Wasan",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Drug Dev Ind Pharm",
            "volume": "31",
            "issn": "4-5",
            "pages": "331--338",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Literature values of terminal half-lives of clozapine are dependent on the time of the last data point",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Fang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "E"
                    ],
                    "last": "Mosier",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Pharm Pharm Sci",
            "volume": "17",
            "issn": "2",
            "pages": "187--196",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Clozapine levels after clozapine discontinuation",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Henighan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Stanilla",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Simpson",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "J Clin Psychopharmacol",
            "volume": "16",
            "issn": "2",
            "pages": "193--197",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Clinical pharmacokinetics handbook",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Bauer",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Bertilsson L. Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Jerling",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Lindstr\u00f6m",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Bondesson",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Ther Drug Monit",
            "volume": "16",
            "issn": "4",
            "pages": "368--74",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Plasma clozapine and norclozapine in patients prescribed different brands of clozapine (Clozaril, Denzapine, and Zaponex)",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Couchman",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Morgan",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "P"
                    ],
                    "last": "Spencer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Johnston",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Flanagan",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Ther Drug Monit",
            "volume": "32",
            "issn": "5",
            "pages": "624--631",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Couchman",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Morgan",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "P"
                    ],
                    "last": "Spencer",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Flanagan",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Ther Drug Monit",
            "volume": "32",
            "issn": "4",
            "pages": "438--485",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Plasma clozapine concentration coefficients of variation in a long-term study",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "J"
                    ],
                    "last": "Diaz",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Josiassen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "B"
                    ],
                    "last": "Cooper",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Simpson",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Schizophr Res",
            "volume": "72",
            "issn": "2-3",
            "pages": "131--136",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Palego",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Biondi",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Giannaccini",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Sarno",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Elmi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ciapparelli",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Prog Neuropsychopharmacol Biol Psychiatry",
            "volume": "26",
            "issn": "3",
            "pages": "473--80",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Clozapine and norclozapine plasma concentrations and clinical response of treatmentrefractory schizophrenic patients",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Perry",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "D"
                    ],
                    "last": "Miller",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "V"
                    ],
                    "last": "Arndt",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Cadoret",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Am J Psychiatry",
            "volume": "148",
            "issn": "2",
            "pages": "231--236",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Vanderzwaag",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mcgee",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Mcevoy",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Freudenreich",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Wilson",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "B"
                    ],
                    "last": "Cooper",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Am J Psychiatry",
            "volume": "153",
            "issn": "12",
            "pages": "1579--84",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Relationship between clozapine dose, serum concentration, and clinical outcome in children and adolescents in clinical practice",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wohkittel",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gerlach",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Taurines",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wewetzer",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Unterecker",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Burger",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "J Neural Transm",
            "volume": "123",
            "issn": "8",
            "pages": "1021--1052",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "New concepts in the statistical assessment of bioequivalence metrics",
            "authors": [],
            "year": 1997,
            "venue": "FDA Individual Bioequivalence Working Group. Individual bioequivalence",
            "volume": "33",
            "issn": "",
            "pages": "1--6",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "FDA position on product selection for 'narrow therapeutic index' drugs",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Williams",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Am J Health Syst Pharm",
            "volume": "54",
            "issn": "14",
            "pages": "1630--1632",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Does clozapine decrease smoking?",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "J"
                    ],
                    "last": "Diaz",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Josiassen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "B"
                    ],
                    "last": "Cooper",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Simpson",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Prog Neuropsychopharmacol Biol Psychiatry",
            "volume": "29",
            "issn": "5",
            "pages": "757--62",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "A case report that suggested that aspirin's effects on valproic acid metabolism may contribute to valproic acid's inducer effects on clozapine metabolism",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Riesselman",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Strobl",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "T"
                    ],
                    "last": "Cooley",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J Clin Psychopharmacol",
            "volume": "33",
            "issn": "6",
            "pages": "812--816",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Thirty years of both ignorance and clinical experience suggest that clozapine intoxication during co-occurring infections and inflammation may have higher morbidity and mortality than is currently believed",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Psychosomatics",
            "volume": "60",
            "issn": "2",
            "pages": "221--223",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Pneumonia can cause clozapine intoxication: a case report. Psychosomatics",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "Y"
                    ],
                    "last": "Zhen",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "L"
                    ],
                    "last": "Ge",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "Y"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "L"
                    ],
                    "last": "Tang",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "58",
            "issn": "",
            "pages": "652--658",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Two cases of high serum clozapine concentrations occurring during inflammation in Chinese patients",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "L"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "B"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "Y"
                    ],
                    "last": "Zhuang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "Q"
                    ],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Int J Psychiatry Med",
            "volume": "53",
            "issn": "4",
            "pages": "292--305",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Catatonia secondary to sudden clozapine withdrawal: a case with three repeated episodes and a literature review. Case Rep Psychiatry",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bilbily",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Mccollum",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Cytochrome P450 and therapeutic drug monitoring with respect to clozapine. Eur Neuropsychopharmacol",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Buur-Rasmussen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Br\u00f8sen",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "",
            "volume": "9",
            "issn": "",
            "pages": "453--462",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Serum clozapine levels: a review of their clinical utility",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Greenwood-Smith",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "I"
                    ],
                    "last": "Lubman",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Castle",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Psychopharmacol",
            "volume": "17",
            "issn": "2",
            "pages": "234--242",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Therapeutic drug monitoring of clozapine treatment. Therapeutic threshold value for serum clozapine concentrations",
            "authors": [
                {
                    "first": "O",
                    "middle": [
                        "V"
                    ],
                    "last": "Olesen",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Clin Pharmacokinet",
            "volume": "34",
            "issn": "6",
            "pages": "497--502",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Therapeutic drug monitoring of clozapine in relapse prevention: a five-year prospective study",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Gaertner",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Gaertner",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Vonthein",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Dietz",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Clin Psychopharmacol",
            "volume": "21",
            "issn": "3",
            "pages": "305--315",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Clozapine plasma level monitoring for prediction of rehospitalization schizophrenic outpatients",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Stieffenhofer",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Saglam",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Schmidtmann",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Silver",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hiemke",
                    "suffix": ""
                },
                {
                    "first": "Konrad",
                    "middle": [
                        "A"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Pharmacopsychiatry",
            "volume": "44",
            "issn": "2",
            "pages": "55--64",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "Q"
                    ],
                    "last": "Xiang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "J"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "Z"
                    ],
                    "last": "Weng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "M"
                    ],
                    "last": "Zhai",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "B"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "J"
                    ],
                    "last": "Cai",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Schizophr Res",
            "volume": "83",
            "issn": "2-3",
            "pages": "201--211",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Serum level of clozapine and relapse",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ulrich",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Wolf",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Staedt",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Ther Drug Monit",
            "volume": "25",
            "issn": "2",
            "pages": "252--257",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Therapeutic drug monitoring of clozapine and relapse-a retrospective study of routine clinical data",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ulrich",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Baumann",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Wolf",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lehmann",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Peters",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Bogerts",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Int J Clin Pharmacol Ther",
            "volume": "41",
            "issn": "1",
            "pages": "3--13",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Clinical pharmacopsychology: conceptual foundations and emerging tasks",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Fava",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Tomba",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bech",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Psychother Psychosom",
            "volume": "86",
            "issn": "3",
            "pages": "134--174",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Reviving research on medication attitudes for improving pharmacotherapy: focusing on adherence",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "De Las Cuevas",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Psychother Psychosom",
            "volume": "86",
            "issn": "2",
            "pages": "73--82",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "The art of pharmacotherapy: reflections on pharmacophobia",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "De Las",
                    "middle": [],
                    "last": "Cuevas",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J Clin Psychopharmacol",
            "volume": "37",
            "issn": "2",
            "pages": "131--138",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Mccutcheon",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Beck",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Bloomfield",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "R"
                    ],
                    "last": "Marques",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rogdaki",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "D"
                    ],
                    "last": "Howes",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "J Psychopharmacol",
            "volume": "29",
            "issn": "8",
            "pages": "892--899",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Mccutcheon",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Beck",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "&apos;ambrosio",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Donocik",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gobjila",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Jauhar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Development and validation of the Patient's Health Belief Questionnaire on Psychiatric Treatment. Patient Prefer Adherence",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "De Las Cuevas",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "13",
            "issn": "",
            "pages": "527--563",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology",
            "authors": [
                {
                    "first": "O",
                    "middle": [
                        "D"
                    ],
                    "last": "Howes",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Mccutcheon",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Agid",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "De Bartolomeis",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "J"
                    ],
                    "last": "Van Beveren",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Birnbaum",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Am J Psychiatry",
            "volume": "174",
            "issn": "3",
            "pages": "216--245",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "The role of clozapine in treatment-resistant schizophrenia",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Kane",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Correll",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "JAMA Psychiatry",
            "volume": "73",
            "issn": "3",
            "pages": "187--195",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Clozapine for treatment-resistant schizophrenia: still the gold standard? CNS Drugs",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Taylor",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "31",
            "issn": "",
            "pages": "177--80",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Functional neuroimaging in treatment resistant schizophrenia: A systematic review",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Molent",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Olivo",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Wolf",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Balestrieri",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Sambataro",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Neurosci Biobehav Rev",
            "volume": "104",
            "issn": "",
            "pages": "178--90",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Clinical course, neurobiology and therapeutic approaches to treatment resistant schizophrenia. Toward an integrated view. Front Psychiatry",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "C"
                    ],
                    "last": "Leung",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Gadelrab",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Ntephe",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "K"
                    ],
                    "last": "Mc-Guire",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Demjaha",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "10",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "The social and economic burden of treatment-resistant schizophrenia: a systematic literature review",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Kennedy",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Altar",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Degtiar",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Hornberger",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Int Clin Psychopharmacol",
            "volume": "29",
            "issn": "2",
            "pages": "63--76",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hjorth\u00f8j",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "E"
                    ],
                    "last": "St\u00fcrup",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Mcgrath",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "295--301",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "Antipsychotic treatment and mortality in schizophrenia",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Torniainen",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Mittendorfer-Rutz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Tanskanen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bj\u00f6rkenstam",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Suvisaari",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Alexanderson",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Schizophr Bull",
            "volume": "41",
            "issn": "3",
            "pages": "656--63",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1-12.5 years",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Vermeulen",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Van Rooijen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Van De Kerkhof",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Sutterland",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Correll",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "De Haan",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Schizophr Bull",
            "volume": "45",
            "issn": "2",
            "pages": "315--344",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Taipale",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Tanskanen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Meht\u00e4l\u00e4",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Vattulainen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Correll",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Tiihonen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "19",
            "issn": "",
            "pages": "61--69",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "Clozapine and allcause mortality in treatment-resistant schizophrenia: a historical cohort study",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "D"
                    ],
                    "last": "Hayes",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Jewell",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Kadra",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shetty",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Maccabe",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Pathophysiology and clinical trials have limitations in some areas of medicine: focus on psychiatry (letter commenting",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "B"
                    ],
                    "last": "Stephens",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Clin Epidemiol",
            "volume": "67",
            "issn": "4",
            "pages": "126--133",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "Meta-analysis: statistical alchemy for the 21st century",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "R"
                    ],
                    "last": "Feinstein",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "J Clin Epidemiol",
            "volume": "48",
            "issn": "1",
            "pages": "71--80",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "Critical issues on the use of network meta-analysis in psychiatry",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Yildiz",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Vieta",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Correll",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Nikodem",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Baldessarini",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Harv Rev Psychiatry",
            "volume": "",
            "issn": "6",
            "pages": "367--72",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "Clozapine v. first-and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Siskind",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mccartney",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Goldschlager",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kisely",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Br J Psychiatry",
            "volume": "209",
            "issn": "5",
            "pages": "385--92",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Clozapine response rates among people with treatmentresistant schizophrenia: data from a systematic review and meta-analysis. Can J Psychiatry",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Siskind",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Siskind",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kisely",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "62",
            "issn": "",
            "pages": "772--779",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "T"
                    ],
                    "last": "Samara",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dold",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gianatsi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nikolakopoulou",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Helfer",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Salanti",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "JAMA Psychiatry",
            "volume": "73",
            "issn": "3",
            "pages": "199--210",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Huhn",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nikolakopoulou",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Schneider-Thoma",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Krause",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Samara",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Peter",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Lancet",
            "volume": "394",
            "issn": "",
            "pages": "939--51",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "Use of clozapine in schizophrenia",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Mustafa",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "JAMA Psychiatry",
            "volume": "73",
            "issn": "10",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "Use of clozapine in schizophrenia",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Mcevoy",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "JAMA Psychiatry",
            "volume": "73",
            "issn": "10",
            "pages": "1097--1105",
            "other_ids": {}
        },
        "BIBREF82": {
            "ref_id": "b82",
            "title": "Evidence-based medicine was bound to fail: a report to Alvan Feinstein",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Fava",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J Clin Epidemiol",
            "volume": "84",
            "issn": "",
            "pages": "3--7",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "The impact of clozapine on hospital use: a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Land",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Siskind",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Mcardle",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kisely",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Winckel",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Hollingworth",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Acta Psychiatr Scand",
            "volume": "135",
            "issn": "4",
            "pages": "296--309",
            "other_ids": {}
        },
        "BIBREF85": {
            "ref_id": "b85",
            "title": "Association with hospitalization and all-cause discontinuation among patients with schizophrenia on clozapine vs other oral second-generation antipsychotics: a systematic review and meta-analysis of cohort studies",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Masuda",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Misawa",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Takase",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Kane",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Correll",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "JAMA Psychiatry",
            "volume": "76",
            "issn": "10",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF86": {
            "ref_id": "b86",
            "title": "The pursuit of euthymia. World Psychiatry",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Fava",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Guidi",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "19",
            "issn": "",
            "pages": "40--50",
            "other_ids": {}
        },
        "BIBREF87": {
            "ref_id": "b87",
            "title": "Behavioral toxicity of antipsychotic drugs",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Van Putten",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Marder",
                    "suffix": ""
                }
            ],
            "year": 1987,
            "venue": "J Clin Psychiatry",
            "volume": "48",
            "issn": "",
            "pages": "13--22",
            "other_ids": {}
        },
        "BIBREF88": {
            "ref_id": "b88",
            "title": "Behavioral toxicity revisited: iatrogenic comorbidity in psychiatric evaluation and treatment",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Fava",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Cosci",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Offidani",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Guidi",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "J Clin Psychopharmacol",
            "volume": "36",
            "issn": "6",
            "pages": "550--553",
            "other_ids": {}
        },
        "BIBREF89": {
            "ref_id": "b89",
            "title": "Iatrogenic factors in psychopathology",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Fava",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Rafanelli",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Psychother Psychosom",
            "volume": "88",
            "issn": "3",
            "pages": "129--169",
            "other_ids": {}
        },
        "BIBREF90": {
            "ref_id": "b90",
            "title": "Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Leucht",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cipriani",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Spineli",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Mavridis",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Orey",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Richter",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Lancet",
            "volume": "382",
            "issn": "9896",
            "pages": "951--62",
            "other_ids": {}
        },
        "BIBREF91": {
            "ref_id": "b91",
            "title": "Clozapine and tardive movement disorders: a review",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Hazari",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kate",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Grover",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Asian J Psychiatr",
            "volume": "6",
            "issn": "6",
            "pages": "439--51",
            "other_ids": {}
        },
        "BIBREF92": {
            "ref_id": "b92",
            "title": "EPS profiles: the atypical antipsychotics are not all the same",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Weiden",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Psychiatr Pract",
            "volume": "13",
            "issn": "1",
            "pages": "13--24",
            "other_ids": {}
        },
        "BIBREF93": {
            "ref_id": "b93",
            "title": "Akathisia: an updated review focusing on second-generation antipsychotics",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Kane",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "W"
                    ],
                    "last": "Fleischhacker",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Hansen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Perlis",
                    "suffix": ""
                },
                {
                    "first": "Assun\u00e7\u00e3o-Talbott",
                    "middle": [],
                    "last": "Pikalov A 3rd",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Clin Psychiatry",
            "volume": "70",
            "issn": "5",
            "pages": "627--670",
            "other_ids": {}
        },
        "BIBREF94": {
            "ref_id": "b94",
            "title": "Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Levin",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "N"
                    ],
                    "last": "Chengappa",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "K"
                    ],
                    "last": "Kambhampati",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Mahdavi",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ganguli",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "J Clin Psychiatry",
            "volume": "53",
            "issn": "7",
            "pages": "248--51",
            "other_ids": {}
        },
        "BIBREF95": {
            "ref_id": "b95",
            "title": "Clozapine and jaw dyskinesia: a case report",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Moral",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Camu\u00f1as",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "J Clin Psychiatry",
            "volume": "52",
            "issn": "12",
            "pages": "494--499",
            "other_ids": {}
        },
        "BIBREF96": {
            "ref_id": "b96",
            "title": "Clozapine monotherapy as a treatment for antipsychotic-induced tardive dyskinesia: a meta-analysis",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "Q"
                    ],
                    "last": "Mentzel",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Van Der Snoek",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lieverse",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Oorschot",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Viechtbauer",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Bloemen",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "J Clin Psychiatry",
            "volume": "79",
            "issn": "6",
            "pages": "17--11852",
            "other_ids": {}
        },
        "BIBREF97": {
            "ref_id": "b97",
            "title": "Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Pardis",
                    "suffix": ""
                },
                {
                    "first": "Remington",
                    "middle": [
                        "G"
                    ],
                    "last": "Panda",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lemez",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Agid",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Psychopharmacol",
            "volume": "33",
            "issn": "10",
            "pages": "1187--98",
            "other_ids": {}
        },
        "BIBREF98": {
            "ref_id": "b98",
            "title": "Long-term response to clozapine and its clinical correlates in the treatment of tardive movement syndromes: a naturalistic observational study in patients with psychotic disorders",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Baek",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bae",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Choi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "S"
                    ],
                    "last": "Hong",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Clin Psychopharmacol",
            "volume": "39",
            "issn": "6",
            "pages": "591--597",
            "other_ids": {}
        },
        "BIBREF99": {
            "ref_id": "b99",
            "title": "Overcoming barriers to effective management of tardive dyskinesia. Neuropsychiatr Dis Treat",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "N"
                    ],
                    "last": "Caroff",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "15",
            "issn": "",
            "pages": "785--94",
            "other_ids": {}
        },
        "BIBREF100": {
            "ref_id": "b100",
            "title": "Efficacy of typical and atypical antipsychotic medication on hostility in patients with psychosisspectrum disorders: a review and meta-analysis",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "D"
                    ],
                    "last": "Faay",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Czobor",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "E"
                    ],
                    "last": "Sommer",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Neuropsychopharmacology",
            "volume": "43",
            "issn": "12",
            "pages": "2340--2349",
            "other_ids": {}
        },
        "BIBREF101": {
            "ref_id": "b101",
            "title": "The psychopharmacology of violence: making sensible decisions",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Citrome",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Volavka",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "CNS Spectr",
            "volume": "19",
            "issn": "5",
            "pages": "411--419",
            "other_ids": {}
        },
        "BIBREF102": {
            "ref_id": "b102",
            "title": "Long-term clinical and social outcome studies in schizophrenia in relation to the cognitive and emotional side effects of antipsychotic drugs",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "H"
                    ],
                    "last": "Lindstr\u00f6m",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Acta Psychiatr Scand Suppl",
            "volume": "380",
            "issn": "",
            "pages": "74--80",
            "other_ids": {}
        },
        "BIBREF103": {
            "ref_id": "b103",
            "title": "Atypical antipsychotic drugs and long-term outcome in schizophrenia",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Weiden",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Aquila",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Standard",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "J Clin Psychiatry",
            "volume": "57",
            "issn": "11",
            "pages": "53--60",
            "other_ids": {}
        },
        "BIBREF104": {
            "ref_id": "b104",
            "title": "Awakening\" from schizophrenia: intramolecular polypharmacy and the atypical antipsychotics",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Stahl",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Clin Psychiatry",
            "volume": "58",
            "issn": "9",
            "pages": "381--383",
            "other_ids": {}
        },
        "BIBREF105": {
            "ref_id": "b105",
            "title": "Worldwide differences in regulations of clozapine use",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Nielsen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Young",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Ifteni",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kishimoto",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "T"
                    ],
                    "last": "Xiang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "F"
                    ],
                    "last": "Schulte",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "CNS Drugs",
            "volume": "30",
            "issn": "2",
            "pages": "149--61",
            "other_ids": {}
        },
        "BIBREF107": {
            "ref_id": "b107",
            "title": "Clozapine underutilization and discontinuation in African Americans due to leucopenia",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Kelly",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kreyenbuhl",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Dixon",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Love",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Medoff",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "R"
                    ],
                    "last": "Conley",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Schizophr Bull",
            "volume": "33",
            "issn": "5",
            "pages": "1221--1225",
            "other_ids": {}
        },
        "BIBREF108": {
            "ref_id": "b108",
            "title": "Clozapine-induced agranulocytosis/granulocytopenia: mechanisms and monitoring",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wici\u0144ski",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "W\u0119clewicz",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Curr Opin Hematol",
            "volume": "25",
            "issn": "1",
            "pages": "22--30",
            "other_ids": {}
        },
        "BIBREF109": {
            "ref_id": "b109",
            "title": "Meta-analysis examining the epidemiology of clozapine-associated neutropenia",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Myles",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Myles",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Large",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kisely",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Galletly",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Acta Psychiatr Scand",
            "volume": "138",
            "issn": "2",
            "pages": "101--110",
            "other_ids": {}
        },
        "BIBREF110": {
            "ref_id": "b110",
            "title": "The prevalence of agranulocytosis and related death in clozapinetreated patients: a comprehensive metaanalysis of observational studies",
            "authors": [
                {
                    "first": "X",
                    "middle": [
                        "H"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "M"
                    ],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "B"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "W"
                    ],
                    "last": "Rao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Psychol Med",
            "volume": "50",
            "issn": "4",
            "pages": "583--94",
            "other_ids": {}
        },
        "BIBREF111": {
            "ref_id": "b111",
            "title": "Clozapine-Induced Agranulocytosis Consortium. Genome-wide common and rare variant analysis provides novel insights into clozapineassociated neutropenia",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Legge",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Hamshere",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ripke",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "F"
                    ],
                    "last": "Pardinas",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "I"
                    ],
                    "last": "Goldstein",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Rees",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Mol Psychiatry",
            "volume": "22",
            "issn": "10",
            "pages": "1502--1510",
            "other_ids": {}
        },
        "BIBREF112": {
            "ref_id": "b112",
            "title": "Pharmacogenetic testing in psychiatry: a review of features and clinical realities",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Arranz",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Rua\u00f1o",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Clin Lab Med",
            "volume": "28",
            "issn": "4",
            "pages": "599--617",
            "other_ids": {}
        },
        "BIBREF113": {
            "ref_id": "b113",
            "title": "Toxic clozapine serum levels during inflammatory reactions",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Pfuhlmann",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hiemke",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Unterecker",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Burger",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Schmidtke",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Riederer",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Clin Psychopharmacol",
            "volume": "29",
            "issn": "4",
            "pages": "392--396",
            "other_ids": {}
        },
        "BIBREF114": {
            "ref_id": "b114",
            "title": "Antipsychotic medication exposure, clozapine, and pneumonia: results from a self-controlled study",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Rohde",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Siskind",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Nielsen",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Acta Psychiatr Scand",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF116": {
            "ref_id": "b116",
            "title": "Mortality in current and former users of clozapine",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Walker",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "L"
                    ],
                    "last": "Lanza",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Arellano",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "J"
                    ],
                    "last": "Rothman",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Epidemiology",
            "volume": "8",
            "issn": "6",
            "pages": "671--678",
            "other_ids": {}
        },
        "BIBREF117": {
            "ref_id": "b117",
            "title": "Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Douglas-Hall",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Olofinjana",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Whiskey",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Thomas",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Br J Psychiatry",
            "volume": "194",
            "issn": "2",
            "pages": "165--172",
            "other_ids": {}
        },
        "BIBREF118": {
            "ref_id": "b118",
            "title": "Schizophrenia past clozapine\": reasons for clozapine discontinuation, mortality, and alternative antipsychotic prescribing",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Mustafa",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Burke",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Abukmeil",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Scanlon",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cox",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Pharmacopsychiatry",
            "volume": "48",
            "issn": "1",
            "pages": "11--15",
            "other_ids": {}
        },
        "BIBREF119": {
            "ref_id": "b119",
            "title": "De Las Cuevas C. Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "J"
                    ],
                    "last": "Sanz",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "N"
                    ],
                    "last": "Nor\u00e9n",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "World Psychiatry",
            "volume": "19",
            "issn": "1",
            "pages": "120--121",
            "other_ids": {}
        },
        "BIBREF120": {
            "ref_id": "b120",
            "title": "Clinical relevance of the multifaceted relationship between clozapine and inflammation",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Verdoux",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "Y"
                    ],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Gen Psychiatr. Forthcoming",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF121": {
            "ref_id": "b121",
            "title": "Clozapine and tuberculosis. Psychosomatics",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Landry",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Deschamps",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Tanguay",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tessier",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "539--579",
            "other_ids": {}
        },
        "BIBREF122": {
            "ref_id": "b122",
            "title": "Antipsychotic drugs and risk of newly diagnosed tuberculosis in schizophrenia",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "C"
                    ],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "C"
                    ],
                    "last": "Hung",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "T"
                    ],
                    "last": "Liao",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "H"
                    ],
                    "last": "Pan",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "C"
                    ],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Psychiatry Clin Neurosci",
            "volume": "72",
            "issn": "10",
            "pages": "789--800",
            "other_ids": {}
        },
        "BIBREF123": {
            "ref_id": "b123",
            "title": "Increased use of antibiotics in clozapine-treated patients",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Landry",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Benaliouad",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tessier",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Int Clin Psychopharmacol",
            "volume": "18",
            "issn": "5",
            "pages": "297--305",
            "other_ids": {}
        },
        "BIBREF124": {
            "ref_id": "b124",
            "title": "Increased use of antibiotics in patients treated with clozapine",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Nielsen",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Foldager",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Meyer",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Eur Neuropsychopharmacol",
            "volume": "19",
            "issn": "7",
            "pages": "483--489",
            "other_ids": {}
        },
        "BIBREF125": {
            "ref_id": "b125",
            "title": "Clozapine is associated with secondary antibody deficiency",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ponsford",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Castle",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tahir",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Robinson",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wade",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Steven",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Br J Psychiatry",
            "volume": "214",
            "issn": "",
            "pages": "1--7",
            "other_ids": {}
        },
        "BIBREF126": {
            "ref_id": "b126",
            "title": "Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Kenis",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Bosmans",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Maes",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Schizophr Res",
            "volume": "42",
            "issn": "2",
            "pages": "157--64",
            "other_ids": {}
        },
        "BIBREF127": {
            "ref_id": "b127",
            "title": "A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. Expert Rev Clin Pharmacol",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Cicala",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Barbieri",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Spina",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "12",
            "issn": "",
            "pages": "219--253",
            "other_ids": {}
        },
        "BIBREF129": {
            "ref_id": "b129",
            "title": "Pharmacological and behavioral management of some often-overlooked clozapine-induced side effects",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sagy",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Weizman",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Katz",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Int Clin Psychopharmacol",
            "volume": "29",
            "issn": "6",
            "pages": "313--320",
            "other_ids": {}
        },
        "BIBREF130": {
            "ref_id": "b130",
            "title": "The Clozapine Handbook: Stahl's Handbooks",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Meyer",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Stahl",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF131": {
            "ref_id": "b131",
            "title": "Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Papola",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ostuzzi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Gastaldon",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "P"
                    ],
                    "last": "Morgano",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Dragioti",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "F"
                    ],
                    "last": "Carvalho",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Acta Psychiatr Scand",
            "volume": "140",
            "issn": "3",
            "pages": "227--270",
            "other_ids": {}
        },
        "BIBREF132": {
            "ref_id": "b132",
            "title": "Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Siskind",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sidhu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cross",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "T"
                    ],
                    "last": "Chua",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Myles",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Aust N Z J Psychiatry",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1177/0004867419898760"
                ]
            }
        },
        "BIBREF134": {
            "ref_id": "b134",
            "title": "Factors influencing the incidence of lamotrigine-related skin rash",
            "authors": [
                {
                    "first": "I",
                    "middle": [
                        "C"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "E"
                    ],
                    "last": "Mawer",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Sander",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Ann Pharmacother",
            "volume": "33",
            "issn": "10",
            "pages": "1037--1079",
            "other_ids": {}
        },
        "BIBREF135": {
            "ref_id": "b135",
            "title": "Lamotrigine-induced severe cutaneous adverse reaction: update data from 1999-2014",
            "authors": [
                {
                    "first": "X",
                    "middle": [
                        "Q"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Lv",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "F"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "S"
                    ],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "J Clin Neurosci",
            "volume": "22",
            "issn": "6",
            "pages": "1005--1016",
            "other_ids": {}
        },
        "BIBREF136": {
            "ref_id": "b136",
            "title": "Antiepilepsy drugs and the immune system",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Godhwani",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Bahna",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Ann Allergy Asthma Immunol",
            "volume": "117",
            "issn": "6",
            "pages": "634--674",
            "other_ids": {}
        },
        "BIBREF137": {
            "ref_id": "b137",
            "title": "A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "J"
                    ],
                    "last": "Ronaldson",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "B"
                    ],
                    "last": "Fitzgerald",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Topliss",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Mcneil",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Aust N Z J Psychiatry",
            "volume": "45",
            "issn": "6",
            "pages": "458--65",
            "other_ids": {}
        },
        "BIBREF138": {
            "ref_id": "b138",
            "title": "Cardiovascular disease in clozapine-treated patients: evidence, mechanisms and management",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "J"
                    ],
                    "last": "Ronaldson",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "CNS Drugs",
            "volume": "31",
            "issn": "9",
            "pages": "777--95",
            "other_ids": {}
        },
        "BIBREF139": {
            "ref_id": "b139",
            "title": "The multiple histories of Western Asia: perspectives from ancient and modern genomes",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "O"
                    ],
                    "last": "Taskent",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Gokcumen",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Hum Biol",
            "volume": "89",
            "issn": "2",
            "pages": "107--124",
            "other_ids": {}
        },
        "BIBREF140": {
            "ref_id": "b140",
            "title": "Incidence and management of clozapine-induced myocarditis in a large tertiary hospital",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Higgins",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "San",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lagnado",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chua",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Mihic",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Can J Psychiatry",
            "volume": "64",
            "issn": "8",
            "pages": "561--568",
            "other_ids": {}
        },
        "BIBREF141": {
            "ref_id": "b141",
            "title": "Clozapine-induced myocarditis in Canada: evidence from spontaneous reports",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "H"
                    ],
                    "last": "Neufeld",
                    "suffix": ""
                },
                {
                    "first": "Remington",
                    "middle": [
                        "G"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Schizophr Res",
            "volume": "206",
            "issn": "",
            "pages": "462--465",
            "other_ids": {}
        },
        "BIBREF142": {
            "ref_id": "b142",
            "title": "Clozapine-induced myocarditis may be associated with rapid titration: A case report verified with autopsy",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Chopra",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Int J Psychiatry Med",
            "volume": "51",
            "issn": "1",
            "pages": "104--119",
            "other_ids": {}
        },
        "BIBREF143": {
            "ref_id": "b143",
            "title": "Clozapine-induced myocarditis: prevention and considerations in rechallenge",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Cook",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "A"
                    ],
                    "last": "Ferguson",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "O"
                    ],
                    "last": "Cotes",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "W"
                    ],
                    "last": "Heinrich",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Schwartz",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Psychosomatics",
            "volume": "56",
            "issn": "6",
            "pages": "685--90",
            "other_ids": {}
        },
        "BIBREF144": {
            "ref_id": "b144",
            "title": "A comparative study of detection of myocarditis induced by clozapine: with and without cardiac monitoring",
            "authors": [
                {
                    "first": "An\u0131l",
                    "middle": [],
                    "last": "Ya\u011fc\u0131o\u011flu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "E"
                    ],
                    "last": "Ertu\u011frul",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Karaka\u015fl\u0131",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "A\u011fao\u011flu",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Ak",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Karahan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Psychiatry Res",
            "volume": "279",
            "issn": "",
            "pages": "90--97",
            "other_ids": {}
        },
        "BIBREF145": {
            "ref_id": "b145",
            "title": "Clozapine-induced myocarditis during co-administration of valproate: A case report",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Jaho\u0142kowski",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Niewiadomska",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wci\u00f3rka",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kowalski",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "\u015awitaj",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Psychiatr Pol",
            "volume": "53",
            "issn": "5",
            "pages": "997--1002",
            "other_ids": {}
        },
        "BIBREF146": {
            "ref_id": "b146",
            "title": "Clozapine-induced myocarditis: follow-up for 3.5 years after successful retrial",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Otsuka",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Idemoto",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hosoda",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Imamura",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Aoki",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Gen Fam Med",
            "volume": "20",
            "issn": "3",
            "pages": "114--121",
            "other_ids": {}
        },
        "BIBREF147": {
            "ref_id": "b147",
            "title": "Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Palmer",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Mclean",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Ellis",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Harrison-Woolrych",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Clin Psychiatry",
            "volume": "69",
            "issn": "5",
            "pages": "759--68",
            "other_ids": {}
        },
        "BIBREF148": {
            "ref_id": "b148",
            "title": "FDA strengthens warning that untreated constipation caused by schizophrenia medicine clozapine (Clozaril) can lead to serious bowel problems",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF149": {
            "ref_id": "b149",
            "title": "Clozapine-induced gastrointestinal hypomotility: a 22-year bi-national pharmacovigilance study of serious or fatal 'slow gut' reactions, and comparison with international drug safety advice",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Every-Palmer",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Ellis",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "CNS Drugs",
            "volume": "31",
            "issn": "8",
            "pages": "699--709",
            "other_ids": {}
        },
        "BIBREF150": {
            "ref_id": "b150",
            "title": "Prevalence and predictors of clozapine-associated constipation: a systematic review and metaanalysis",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Shirazi",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Stubbs",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gomez",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Gaughran",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Flanagan",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Int J Mol Sci",
            "volume": "17",
            "issn": "6",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF151": {
            "ref_id": "b151",
            "title": "Pharmacological treatment for antipsychotic-related constipation. Cochrane Database Syst Rev",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Every-Palmer",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Newton-Howes",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Clarke",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF152": {
            "ref_id": "b152",
            "title": "The Porirua protocol in the treatment of clozapine-induced gastrointestinal hypomotility and constipation: a pre-and post-treatment study",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Every-Palmer",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Ellis",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Nowitz",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Stanley",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Grant",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Huthwaite",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "CNS Drugs",
            "volume": "31",
            "issn": "1",
            "pages": "75--85",
            "other_ids": {}
        },
        "BIBREF153": {
            "ref_id": "b153",
            "title": "Clozapine and gastrointestinal hypomotility",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "CNS Drugs",
            "volume": "31",
            "issn": "12",
            "pages": "1083--91",
            "other_ids": {}
        },
        "BIBREF154": {
            "ref_id": "b154",
            "title": "Clozapine and sudden death",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Tie",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "D"
                    ],
                    "last": "Walker",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "B"
                    ],
                    "last": "Singleton",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Bursill",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "R"
                    ],
                    "last": "Wyse",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "J"
                    ],
                    "last": "Campbell",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Clin Psychopharmacol",
            "volume": "21",
            "issn": "6",
            "pages": "630--632",
            "other_ids": {}
        },
        "BIBREF155": {
            "ref_id": "b155",
            "title": "Clozapine rechallenge following QTc prolongation",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Law",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Mohan",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Bastiampillai",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dhillon",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Aust N Z J Psychiatry",
            "volume": "48",
            "issn": "2",
            "pages": "198--207",
            "other_ids": {}
        },
        "BIBREF156": {
            "ref_id": "b156",
            "title": "Electrocardiographic abnormalities in patients treated with clozapine",
            "authors": [
                {
                    "first": "U",
                    "middle": [
                        "G"
                    ],
                    "last": "Kang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Kwon",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "M"
                    ],
                    "last": "Ahn",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Chung",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Ha",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "J"
                    ],
                    "last": "Koo",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J Clin Psychiatry",
            "volume": "61",
            "issn": "6",
            "pages": "441--447",
            "other_ids": {}
        },
        "BIBREF157": {
            "ref_id": "b157",
            "title": "QTc prolongation: is clozapine safe? Study of 82 cases before and after clozapine treatment",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Grande",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pons",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Baeza",
                    "suffix": ""
                },
                {
                    "first": "\u00c1",
                    "middle": [],
                    "last": "Torras",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bernardo",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Hum Psychopharmacol",
            "volume": "26",
            "issn": "6",
            "pages": "397--403",
            "other_ids": {}
        },
        "BIBREF158": {
            "ref_id": "b158",
            "title": "Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Raschi",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Poluzzi",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Godman",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Koci",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Moretti",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kalaba",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "PLoS One",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF159": {
            "ref_id": "b159",
            "title": "Clinically relevant interactions between newer antidepressants and second-generation antipsychotics",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Spina",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Expert Opin Drug Metab Toxicol",
            "volume": "10",
            "issn": "5",
            "pages": "721--767",
            "other_ids": {}
        },
        "BIBREF160": {
            "ref_id": "b160",
            "title": "Interactions between antiepileptics and second-generation antipsychotics",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Santoro",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "&apos;arrigo",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Spina",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Expert Opin Drug Metab Toxicol",
            "volume": "8",
            "issn": "3",
            "pages": "311--345",
            "other_ids": {}
        },
        "BIBREF161": {
            "ref_id": "b161",
            "title": "Clozapine-related seizures: experience with 5,629 patients",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "V"
                    ],
                    "last": "Pacia",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Devinsky",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Neurology",
            "volume": "44",
            "issn": "12",
            "pages": "2247--2256",
            "other_ids": {}
        },
        "BIBREF162": {
            "ref_id": "b162",
            "title": "Unexpected falls during clozapine treatment explained by myoclonus. Prim Care Companion CNS Disord",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Mccollum",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Barclay",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "",
            "volume": "20",
            "issn": "",
            "pages": "17--02151",
            "other_ids": {
                "DOI": [
                    "10.4088/PCC.17l02151"
                ]
            }
        },
        "BIBREF163": {
            "ref_id": "b163",
            "title": "Seizure associated with clozapine: incidence, etiology, and management",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Williams",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Park",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "CNS Drugs",
            "volume": "29",
            "issn": "2",
            "pages": "101--112",
            "other_ids": {}
        },
        "BIBREF164": {
            "ref_id": "b164",
            "title": "Association of clozapine with seizures: a brief report involving 222 patients prescribed clozapine. East Asian Arch Psychiatry",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Grover",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Hazari",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chakrabarti",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Avasthi",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "",
            "volume": "25",
            "issn": "",
            "pages": "73--81",
            "other_ids": {}
        },
        "BIBREF165": {
            "ref_id": "b165",
            "title": "Use of anticonvulsants as prophylaxis for seizures in patients on clozapine",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Caetano",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Australas Psychiatry",
            "volume": "22",
            "issn": "1",
            "pages": "78--83",
            "other_ids": {}
        },
        "BIBREF166": {
            "ref_id": "b166",
            "title": "Guidelines for the use of clozapine in individuals with developmental disabilities",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sabaawi",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "N"
                    ],
                    "last": "Singh",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Res Dev Disabil",
            "volume": "27",
            "issn": "3",
            "pages": "309--345",
            "other_ids": {}
        },
        "BIBREF167": {
            "ref_id": "b167",
            "title": "Planning for the optimal design of studies to personalize antipsychotic prescriptions in the post-CATIE era: the clinical and pharmacoepidemiological data suggest that pursuing the pharmacogenetics of metabolic syndrome complications (hypertension, diabetes mellitus and hyperlipidemia) may be a reasonable strategy",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "J"
                    ],
                    "last": "Diaz",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Schizophr Res",
            "volume": "96",
            "issn": "1-3",
            "pages": "185--97",
            "other_ids": {}
        },
        "BIBREF168": {
            "ref_id": "b168",
            "title": "Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Leucht",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Leucht",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Huhn",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Chaimani",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Mavridis",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Helfer",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Am J Psychiatry",
            "volume": "174",
            "issn": "10",
            "pages": "927--969",
            "other_ids": {}
        },
        "BIBREF170": {
            "ref_id": "b170",
            "title": "Clozapine-associated obsessive-compulsive symptoms and their management: a systematic review and analysis of 107 reported cases. Psychother Psychosom",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "D"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Barr",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Stewart",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "F"
                    ],
                    "last": "White",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "G"
                    ],
                    "last": "Honer",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "11",
            "issn": "",
            "pages": "1--10",
            "other_ids": {
                "DOI": [
                    "10.1159/000505876"
                ]
            }
        },
        "BIBREF171": {
            "ref_id": "b171",
            "title": "Antipsychotic-induced dopamine supersensitivity psychosis: pharmacology, criteria, and therapy",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Chouinard",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "N"
                    ],
                    "last": "Samaha",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "A"
                    ],
                    "last": "Chouinard",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "S"
                    ],
                    "last": "Peretti",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kanahara",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Takase",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Psychother Psychosom",
            "volume": "86",
            "issn": "4",
            "pages": "189--219",
            "other_ids": {}
        },
        "BIBREF172": {
            "ref_id": "b172",
            "title": "Anticholinergics to treat clozapine withdrawal",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Stanilla",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "O"
                    ],
                    "last": "White",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Simpson",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "J Clin Psychiatry",
            "volume": "55",
            "issn": "3",
            "pages": "119--139",
            "other_ids": {}
        },
        "BIBREF173": {
            "ref_id": "b173",
            "title": "Clozapine withdrawal resulting in delirium with psychosis: a report of three cases",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Stanilla",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Simpson",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Clin Psychiatry",
            "volume": "58",
            "issn": "6",
            "pages": "252--257",
            "other_ids": {}
        },
        "BIBREF174": {
            "ref_id": "b174",
            "title": "Schizophrenia past clozapine: what works?",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Mustafa",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J Clin Psychopharmacol",
            "volume": "33",
            "issn": "1",
            "pages": "63--71",
            "other_ids": {}
        },
        "BIBREF175": {
            "ref_id": "b175",
            "title": "Clozapine lacks previous clinical efficacy when restarted after a period of discontinuation: a case series",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Grassi",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ferrari",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Epifani",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Dragoni",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Scarone",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Eur Neuropsychopharmacol",
            "volume": "9",
            "issn": "6",
            "pages": "479--81",
            "other_ids": {}
        },
        "BIBREF176": {
            "ref_id": "b176",
            "title": "The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Miodownik",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Lerner",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kibari",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Toder",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Clin Psychiatry",
            "volume": "67",
            "issn": "8",
            "pages": "1204--1212",
            "other_ids": {}
        },
        "BIBREF177": {
            "ref_id": "b177",
            "title": "International trends in clozapine use: a study in 17 countries",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Bachmann",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Aagaard",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bernardo",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Brandt",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cartabia",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Clavenna",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Acta Psychiatr Scand",
            "volume": "136",
            "issn": "1",
            "pages": "37--51",
            "other_ids": {}
        },
        "BIBREF178": {
            "ref_id": "b178",
            "title": "Clozaphobia; fear of prescribers of clozapine for treatment of schizophrenia",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cetin",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF180": {
            "ref_id": "b180",
            "title": "Barriers to using clozapine in treatment-resistant schizophrenia: systematic review",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Farooq",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Choudry",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Naeem",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ayub",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "BJPsych Bull",
            "volume": "43",
            "issn": "1",
            "pages": "8--16",
            "other_ids": {}
        },
        "BIBREF181": {
            "ref_id": "b181",
            "title": "Prescriber and institutional barriers and facilitators of clozapine use: A systematic review",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Verdoux",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Quiles",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Bachmann",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Siskind",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Schizophr Res",
            "volume": "201",
            "issn": "",
            "pages": "10--19",
            "other_ids": {}
        },
        "BIBREF182": {
            "ref_id": "b182",
            "title": "Consumer access to clozapine in Australia: how does this compare to New Zealand and the United Kingdom? Pharm Pract (Granada)",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Knowles",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Mcmillan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Wheeler",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "",
            "volume": "14",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF183": {
            "ref_id": "b183",
            "title": "Patient attitudes to clozapine initiation. Int Clin Psychopharmacol",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Gee",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Shergill",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Taylor",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "32",
            "issn": "",
            "pages": "337--379",
            "other_ids": {}
        },
        "BIBREF184": {
            "ref_id": "b184",
            "title": "Guideline for the Use of Clozapine",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF185": {
            "ref_id": "b185",
            "title": "Clozapine underutilization in the treatment of schizophrenia: how can clozapine prescription rates be improved?",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Bogers",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "F"
                    ],
                    "last": "Schulte",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Van Dijk",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Bakker",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "J Clin Psychopharmacol",
            "volume": "36",
            "issn": "2",
            "pages": "109--120",
            "other_ids": {}
        },
        "BIBREF186": {
            "ref_id": "b186",
            "title": "Outcomes for schizophrenia patients with clozapine treatment: how good does it get?",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Wheeler",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Humberstone",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Robinson",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Psychopharmacol",
            "volume": "23",
            "issn": "8",
            "pages": "957--65",
            "other_ids": {}
        },
        "BIBREF187": {
            "ref_id": "b187",
            "title": "Comments on the role of therapeutic drug monitoring for clozapine",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Preskorn",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Psychiatr Pract",
            "volume": "11",
            "issn": "5",
            "pages": "340--343",
            "other_ids": {}
        },
        "BIBREF188": {
            "ref_id": "b188",
            "title": "What is an adequate trial with clozapine?: therapeutic drug monitoring and time to response in treatment-refractory schizophrenia",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Schulte",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Clin Pharmacokinet",
            "volume": "42",
            "issn": "7",
            "pages": "607--625",
            "other_ids": {}
        },
        "BIBREF189": {
            "ref_id": "b189",
            "title": "Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "Y"
                    ],
                    "last": "Lane",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "K"
                    ],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "P"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Chang",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Clin Psychiatry",
            "volume": "65",
            "issn": "6",
            "pages": "766--71",
            "other_ids": {}
        },
        "BIBREF190": {
            "ref_id": "b190",
            "title": "Commercial pharmacogenetic-based decision-support tools in psychiatry",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Bousman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hopwood",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Lancet Psychiatry",
            "volume": "3",
            "issn": "6",
            "pages": "585--90",
            "other_ids": {}
        },
        "BIBREF191": {
            "ref_id": "b191",
            "title": "Pharmacogenetic tests in psychiatry: from fear to failure to hype",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "J Clin Psychopharmacol",
            "volume": "36",
            "issn": "4",
            "pages": "299--304",
            "other_ids": {}
        },
        "BIBREF192": {
            "ref_id": "b192",
            "title": "What is needed to incorporate clinical pharmacogenetic tests into the practice of psychopharmacotherapy?",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Spina",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Expert Rev Clin Pharmacol",
            "volume": "9",
            "issn": "3",
            "pages": "351--355",
            "other_ids": {}
        },
        "BIBREF193": {
            "ref_id": "b193",
            "title": "Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Bousman",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "W"
                    ],
                    "last": "Dunlop",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Pharmacogenomics J",
            "volume": "18",
            "issn": "5",
            "pages": "613--635",
            "other_ids": {}
        },
        "BIBREF194": {
            "ref_id": "b194",
            "title": "Clozapine pharmacogenomics: a review of efficacy, pharmacokinetics",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "J"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "V"
                    ],
                    "last": "Solomon",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "E"
                    ],
                    "last": "Delisi",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF196": {
            "ref_id": "b196",
            "title": "Impact of CYP1A2 genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and metaanalysis",
            "authors": [
                {
                    "first": "Na",
                    "middle": [],
                    "last": "Takuathung",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hanprasertpong",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Teekachunhatean",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Koonrungsesomboon",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Acta Psychiatr Scand",
            "volume": "139",
            "issn": "1",
            "pages": "15--25",
            "other_ids": {}
        },
        "BIBREF197": {
            "ref_id": "b197",
            "title": "Development of pointof-care testing devices to improve clozapine prescribing habits and patient outcomes",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "N"
                    ],
                    "last": "Kalaria",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Kelly",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Neuropsychiatr Dis Treat",
            "volume": "15",
            "issn": "",
            "pages": "2365--70",
            "other_ids": {}
        },
        "BIBREF198": {
            "ref_id": "b198",
            "title": "Evaluation of the performance of a point-of-care method for total and differential white blood cell count in clozapine users",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "N"
                    ],
                    "last": "Bui",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Bogers",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Njo",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Herruer",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Int J Lab Hematol",
            "volume": "38",
            "issn": "6",
            "pages": "703--712",
            "other_ids": {}
        },
        "BIBREF199": {
            "ref_id": "b199",
            "title": "The role of microsystems integration towards point-of-care clozapine treatment monitoring in schizophrenia",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "E"
                    ],
                    "last": "Winkler",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "O"
                    ],
                    "last": "Stevenson",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "F"
                    ],
                    "last": "Payne",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Kelly",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "IEEE Sens Lett",
            "volume": "2",
            "issn": "1",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1109/LSENS.2017.2782883"
                ]
            }
        },
        "BIBREF200": {
            "ref_id": "b200",
            "title": "Dried blood spot analysis for therapeutic drug monitoring of clozapine",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Geers",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Wehkamp",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Van Hateren",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Koster",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "Y"
                    ],
                    "last": "Fedorenko",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J Clin Psychi",
            "volume": "78",
            "issn": "9",
            "pages": "1211--1219",
            "other_ids": {}
        },
        "BIBREF201": {
            "ref_id": "b201",
            "title": "Development of a hematocrit-insensitive device to collect accurate volumes of dried blood spots without specialized skills for measuring clozapine and its metabolites as model analytes",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Nakahara",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Otani",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ueno",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hashimoto",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "J Chromatogr B Analyt Technol Biomed Life Sci",
            "volume": "",
            "issn": "",
            "pages": "70--79",
            "other_ids": {}
        },
        "BIBREF202": {
            "ref_id": "b202",
            "title": "The stability of amitriptyline N-oxide and clozapine N-oxide on treated and untreated dry blood spot cards",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Temesi",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Swales",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Keene",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Dick",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J Pharm Biomed Anal",
            "volume": "76",
            "issn": "",
            "pages": "164--172",
            "other_ids": {}
        },
        "BIBREF203": {
            "ref_id": "b203",
            "title": "Development of a nomogram for the estimation of long-term adherence to clozapine therapy using neutrophil fluorescence",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Man",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "P\u00e9rez-Pitarch",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Wilting",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "R"
                    ],
                    "last": "Heerdink",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "W"
                    ],
                    "last": "Van Solinge",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Egberts",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Br J Clin Pharmacol",
            "volume": "84",
            "issn": "6",
            "pages": "1228--1265",
            "other_ids": {}
        },
        "BIBREF204": {
            "ref_id": "b204",
            "title": "Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "Y"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sim",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Psychiatry Res",
            "volume": "",
            "issn": "18",
            "pages": "32218--32220",
            "other_ids": {}
        },
        "BIBREF205": {
            "ref_id": "b205",
            "title": "Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia. Cochrane Database Syst Rev",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Barber",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Olotu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Corsi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cipriani",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF206": {
            "ref_id": "b206",
            "title": "Clozapine augmentation with antiepileptic drugs for treatment-resistant schizophrenia: a meta-analysis of randomized controlled trials",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "T"
                    ],
                    "last": "Xiang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "H"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "Q"
                    ],
                    "last": "Xiang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J Clin Psychiatry",
            "volume": "78",
            "issn": "5",
            "pages": "498--505",
            "other_ids": {}
        },
        "BIBREF207": {
            "ref_id": "b207",
            "title": "ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "B"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "B"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "B"
                    ],
                    "last": "Cai",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "H"
                    ],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "J Psychiatr Res",
            "volume": "105",
            "issn": "",
            "pages": "23--32",
            "other_ids": {}
        },
        "BIBREF208": {
            "ref_id": "b208",
            "title": "Lack of ECT effects on clozapine plasma levels in patients with treatment-resistant schizophrenia: Pharmacokinetic evidence from a randomized clinical trial",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Schoretsanitis",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mendelowitz",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Malur",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Braga",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "R"
                    ],
                    "last": "Schooler",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "John",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Schizophr Res",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF209": {
            "ref_id": "b209",
            "title": "Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: A network meta-analysis",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Bai",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Cai",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ding",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Schizophr Res",
            "volume": "185",
            "issn": "",
            "pages": "73--82",
            "other_ids": {}
        },
        "BIBREF211": {
            "ref_id": "b211",
            "title": "Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Keating",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mcwilliams",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Schneider",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hynes",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Cousins",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Strawbridge",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "BMJ Open",
            "volume": "7",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF212": {
            "ref_id": "b212",
            "title": "Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Krause",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Huhn",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Schneider-Thoma",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Bighelli",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Chaimani",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Eur Neuropsychopharmacol",
            "volume": "28",
            "issn": "6",
            "pages": "659--74",
            "other_ids": {}
        },
        "BIBREF213": {
            "ref_id": "b213",
            "title": "A systematic review of the evidence of clozapine's anti-aggressive effects",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Frogley",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Dickens",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Picchioni",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Int J Neuropsychopharmacol",
            "volume": "15",
            "issn": "9",
            "pages": "1351--71",
            "other_ids": {}
        },
        "BIBREF214": {
            "ref_id": "b214",
            "title": "Comparative effect of antipsychotics on risk of self-harm among patients with schizophrenia",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "H"
                    ],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Tsai",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Gau",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "M"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Liao",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Acta Psychiatr Scand",
            "volume": "137",
            "issn": "4",
            "pages": "296--305",
            "other_ids": {}
        },
        "BIBREF215": {
            "ref_id": "b215",
            "title": "Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis. Eur Neuropsychopharmacol",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Krause",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Huhn",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Schneider-Thoma",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Bighelli",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Gutsmiedl",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Leucht",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "29",
            "issn": "",
            "pages": "32--45",
            "other_ids": {}
        },
        "BIBREF216": {
            "ref_id": "b216",
            "title": "Clozapine for treatment-resistant bipolar disorder: a systematic review",
            "authors": [
                {
                    "first": "X",
                    "middle": [
                        "B"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "L"
                    ],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "Y"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Bipolar Disord",
            "volume": "17",
            "issn": "3",
            "pages": "235--282",
            "other_ids": {}
        },
        "BIBREF217": {
            "ref_id": "b217",
            "title": "Problems and progress in the diagnosis and treatment of polydipsia and hyponatremia",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Verghese",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Josiassen",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Schizophr Bull",
            "volume": "22",
            "issn": "3",
            "pages": "455--64",
            "other_ids": {}
        },
        "BIBREF218": {
            "ref_id": "b218",
            "title": "Real-world effectiveness of clozapine for intellectual disability: results from a mirrorimage and a reverse-mirror-image study",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Rohde",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Hilker",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Siskind",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Nielsen",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "J Psychopharmacol",
            "volume": "32",
            "issn": "11",
            "pages": "1197--203",
            "other_ids": {}
        },
        "BIBREF219": {
            "ref_id": "b219",
            "title": "Real-World Effectiveness of clozapine for borderline personality disorder: results from a 2-year mirror-image study",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Rohde",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Polcwiartek",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Correll",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Nielsen",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "J Pers Disord",
            "volume": "32",
            "issn": "6",
            "pages": "823--860",
            "other_ids": {}
        },
        "BIBREF220": {
            "ref_id": "b220",
            "title": "Comparative utility of atypical antipsychotics for the treatment of psychosis in Parkinson's Disease: a systematic review and Bayesian network meta-analysis",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Iketani",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kawasaki",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yamada",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Biol Pharm Bull",
            "volume": "40",
            "issn": "11",
            "pages": "1976--82",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "J.d.L. wrote the first draft. All authors meet criteria for authorship and approved the final manuscript. Since 2015, J.d.L. and C.-J.R. have studied > 3,500 clozapine levels in Asians and reviewed the literature on clozapine levels regarding ethnic differences in metabolism and in inflammation in both Chinese and English languages. Since 2017, J.d.L. and G.S. have written articles developing a model for personalizing antipsychotic dosing using levels and focusing on drug-drug interactions. Since April of 2019, J.d.L. and C.D.C. have focused on the pharmacoepidemiology of clozapine adverse drug reactions.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "] and 25 years later replicated in clozapine. In 1997, two studies ignored by Western clozapine researchers stated that Chinese have lower clozapine metabolism than Caucasians [24, 25]. Then, 20 years later, a well-controlled study using caffeine demonstrated that East Asians have lower CYP1A2 activity [34]. It is now clear that all Asians have lower clozapine metabolism and need half the clozapine dosage used in the US [45-48].",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Online supplementary Box S2 [5, 44-",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988 Sep; 45(9): 789-96. 18 Shilalukey K, Robieux I, Spino M, Greenwald M, Shear N, Koren G. Are current pediatric dose recommendations for intravenous theophylline appropriate? J Asthma. 1993; 30(2): 109-21. 19 Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, et al. Cytokines downregulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol. 1993 Oct; 44(4): 707-15. 20 Bertilsson L, Carrillo JA, Dahl ML, Llerena A, Alm C, Bondesson U, et al. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Br J Clin Pharmacol. 1994 Nov; 38(5): 471-3. 21 Bandelow B, Degner D, Kreusch U, R\u00fcther E. Myocarditis under therapy with clozapine. Schizophr Res. 1995 Nov; 17(3): 293-4. 22 Flockhart DA. Drug interactions, cardiac toxicity, and terfenadine: from bench to clinic? J Clin Psychopharmacol. 1996 Apr; 16(2): 101-3. 23 de Leon J. Highlights of drug package inserts and the website DailyMed: the need for further improvement in package inserts to help busy prescribers. J Clin Psychopharmacol. Chang WH, Lin SK, Lane HY, Hu WH, Jann MW, Lin HN. Clozapine dosages and plasma drug concentrations. J Formos Med Assoc. 1997 Aug; 96(8): 599-605. 25 Chong SA, Tan CH, Khoo YM, Lee HS, Wong KE, Ngui F, et al. Clinical evaluation and plasma clozapine concentrations in Chinese patients with schizophrenia. Ther Drug Monit. Devarajan S, Kutcher SP, Dursun SM. Clozapine and sudden death. Lancet. 2000 Mar; 355(9206): 841. 28 La Grenade L, Graham D, Trontell A. Myocarditis and cardiomyopathy associated with clozapine use in the United States. N Engl J Med. 2001 Jul; 345(3): 224-5. 29 Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, et al.; International Suicide Prevention Trial Study Group. Clo-Leon J, Diaz FJ. Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Sep; 27(6): 1059-63. 32 US Food and Drug Administration. Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances [Internet]. Silver Spring: FDA; 2005 [accessed 2020 Apr 3]. Available at: https://wayback.archive-it.org/7993/20170113112252/ http://www.fda.gov/Drugs/DrugSafety/Post-marketDrugSafetyInformationforPatientsand-Providers/ucm053171.htm. 33 Berk M, Fitzsimons J, Lambert T, Pantelis C, Kulkarni J, Castle D, et al. Monitoring the safe use of clozapine: a consensus view from Victoria, Australia. CNS Drugs. 2007; 21(2): 117-27. 34 Ghotbi R, Christensen M, Roh HK, Ingelman-Sundberg M, Aklillu E, Bertilsson L. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotypephenotype relationship in Swedes and Koreans. Eur J Clin Pharmacol. 2007 Jun; 63(6): 537-46. 35 Cohen D, Bogers JP, van Dijk D, Bakker B, Schulte PF. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy. J Clin Psychiatry. 2012 Oct; 73(10): 1307-12. 36 Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, Wolfe R, McNeil JJ. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study. Schizophr Res. 2012 Nov; 141(2-3): 173-8. 37 Kuo CJ, Yang SY, Liao YT, Chen WJ, Lee WC, Shau WY, et al. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophr Bull. 2013 May; 39(3): 648-57. 38 Ronaldson KJ, Fitzgerald PB, McNeil JJ. Clozapine-induced myocarditis, a widely overlooked adverse reaction. Acta Psychiatr Scand. 2015 Oct; 132(4): 231-40. 39 Freudenreich O. Clozapine-induced myocarditis: prescribe safely but do prescribe. Acta Psychiatr Scand. 2015 Oct; 132(4): 240-1. 40 de Leon J, Tang YL, Baptista T, Cohen D, Schulte PF. Titrating clozapine amidst recommendations proposing high myocarditis risk and rapid titrations. Acta Psychiatr Scand. 2015 Oct; 132(4): 242-3. 41 US Food and Drug and Administration. FDA Modifies Monitoring for Neutropenia Associated with Schizophrenia Medicine Clozapine; Approves New Shared REMS Program for all Clozapine Medicines [Internet]. Silver Spring: FDA; 2015 [accessed 2015 Dec 21]. Available from: www.fda.gov/Drugs/Drug-Safety/ucm461853.htm 42 Rohde C, Polcwiartek C, Kragholm K, Ebdrup BH, Siskind D, Nielsen J. Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study. Acta Psychiatr Scand. 2018 Jan; 137(1): 47-53. 43 Clark SR, Warren NS, Kim G, Jankowiak D, Schubert KO, Kisely S, et al. Elevated clozapine levels associated with infection: A systematic review. Schizophr Res. 2018 Feb; 192: 50-6. 44 Diaz FJ, Josiassen RC, de Leon J. The effect of body weight changes on total plasma clozapine concentrations determined by applying a statistical model to the data from a doubleblind trial. J Clin Psychopharmacol. 2018 Oct; 38(5): 442-6. 45 Ruan CJ, Zang YN, Wang CY, Cheng YH, Sun C, Spina E, et al. Clozapine metabolism in East Asians and Caucasians: a pilot exploration of the prevalence of poor metabolizers and a systematic review. J Clin Psychopharmacol. 2019 Mar/Apr; 39(2): 135-44. 46 Ruan CJ, Wang CY, Tang YL, Lin SK, Lee ST, Hong KS, et al. Exploring the prevalence of clozapine phenotypic poor metabolizers in 4 Asian samples: they ranged between 2% and 13. J Clin Psychopharmacol. 2019 Nov/Dec; 39(6): 644-8. 47 de Leon J, Ruan CJ, Schoretsanitis G, Kane JM. Dose and safety concerns of clozapine: worldwide package inserts need revisions. Schizophr Res. 2020 Jan 8;pii: S0920-9964(19)30579-1. 48 de Leon J, Rajkumar AP, Kaithi AR, Schoretsanitis G, Kane JM, Wang CY, et al. Do Asian patients require only half of the clozapine dose prescribed for Caucasians? A critical overview. Indian J Psychol Med. 2020 Jan; 42(1): 4-10. 49 De Leon J, Sanz EJ, De Las Cuevas C. Data from the World Health Organization's pharmacovigilance database supports the prominent role of pneumonia in mortality associated with clozapine adverse drug reactions. Schizophr Bull. 2020 Jan; 46(1): 1-3.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "The authors thank Lorraine Maw, MA, for editorial assistance. Can-Jun Ruan is supported by a 2019 NARSAD Young Investigator Award from the Brain & Behavior Research Foundation. The authors are grateful to the reviewers and editor who provided important suggestions for improving the article. Moreover, the first",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Acknowledgments"
        }
    ]
}